{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":76,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":76,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"583d3ed4173f","filters":{"venue":"JTO Clinical and Research Reports"}},"results":[{"id":"W4225123144","doi":"10.1016/j.jtocrr.2022.100332","title":"Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Janssen Pharmaceuticals; NIHR Leicester Clinical Research Facility; Eli Lilly Japan; Chugai Pharmaceutical; Pfizer Japan; Merck Sharp and Dohme; EMD Serono; Genentech; Daiichi-Sankyo; National Institute for Health and Care Research; Exelixis; Kissei; Bristol-Myers Squibb; Society for Academic Continuing Medical Education; Comprehensive Cancer Center, City of Hope; Merck KGaA; Boehringer Ingelheim Japan; Taiho Pharmaceutical; F. Hoffmann-La Roche; Takeda Pharmaceutical Company; Novartis Pharma; AbbVie; Bayer; Gilead Sciences; Roche; Novartis; Kyowa Hakko Kirin; Sanofi; Manchester Biomedical Research Centre; Yuhan; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Pfizer; AstraZeneca; Ignyta; Ono Pharmaceutical; Eli Lilly and Company","keywords":"ROS1; Medicine; Term (time); Oncology; Internal medicine; Cancer; Adenocarcinoma; Physics","authors":[{"name":"Alexander Drilon","is_ca":false},{"name":"Chao‐Hua Chiu","is_ca":false},{"name":"Yun Fan","is_ca":false},{"name":"Byoung Chul Cho","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Myung‐Ju Ahn","is_ca":false},{"name":"Matthew Krebs","is_ca":false},{"name":"Stephen V. Liu","is_ca":false},{"name":"Thomas John","is_ca":false},{"name":"Gregory A. Otterson","is_ca":false},{"name":"Daniel S.W. Tan","is_ca":false},{"name":"Tejas Patil","is_ca":false},{"name":"Rafał Dziadziuszko","is_ca":false},{"name":"Erminia Massarelli","is_ca":false},{"name":"Takashi Seto","is_ca":false},{"name":"Robert C. Doebele","is_ca":false},{"name":"Bethany Pitcher","is_ca":true},{"name":"Nino Kurtsikidze","is_ca":false},{"name":"Sebastian Heinzmann","is_ca":false},{"name":"Salvatore Siena","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07867063295629535,"gpt":0.4960975451885746,"spread":0.4174269122322793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00188299,0.0002362374,0.0006855224,0.0001836154,0.0001932959,0.0005335631,0.0002264173,0.0002986826,0.0009397658],"category_scores_gemma":[0.001450351,0.00007290841,0.000615701,0.0001660752,0.0002178092,0.0004578631,0.0002673668,0.0007407124,0.000186205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005927583,"about_ca_system_score_gemma":0.0003223612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003466757,"about_ca_topic_score_gemma":0.0007573575,"domain_scores_codex":[0.9994965,0.0001427668,0.00006419944,0.00007931286,0.0001204871,0.00009671941],"domain_scores_gemma":[0.99897,0.0002935595,0.0003609322,0.00006166118,0.000109197,0.0002045831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1902062,0.004788673,0.2938681,0.001397458,0.003413566,0.0007534279,0.0003214981,0.005893995,0.02628657,0.0002896002,0.002583737,0.470197],"study_design_scores_gemma":[0.01097643,0.1788946,0.7802021,0.0002675403,0.002247078,0.002061089,0.0002144695,0.003821931,0.01316387,0.0004599564,0.007623318,0.00006758888],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919668,0.006913851,0.00009684944,0.0001049354,0.0000205965,0.000032232,0.0003183704,0.000007018854,0.000539365],"genre_scores_gemma":[0.9980094,0.0009764406,0.00006001281,0.00007322301,0.00003816408,0.000024398,0.0005509011,0.000001643317,0.0002657275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00188299,"threshold_uncertainty_score":0.009958267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3175514092","doi":"10.1016/j.jtocrr.2021.100205","title":"Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"Janssen Pharmaceuticals; Loxo Oncology; Chugai Pharmaceutical; Genentech; Free Market Institute, Texas Tech University; National Institutes of Health; Shire; Bayer Fund; Mirati Therapeutics; Clovis Oncology; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Verily Life Sciences; Les Laboratories Pierre Fabre; Merck Sharp and Dohme; Takeda Pharmaceuticals U.S.A.; AbbVie; ACEA Biosciences; Novartis; Celgene; Merck; Spectrum Pharmaceuticals; Sanofi; EMD Serono; Mesothelioma Applied Research Foundation; Heron Therapeutics; Bristol-Myers Squibb; Ono Pharmaceutical; Eli Lilly and Company; AstraZeneca; Pfizer; Boehringer Ingelheim; Amgen; Roche","keywords":"Pembrolizumab; Medicine; Brain metastasis; Internal medicine; Chemotherapy; Lung cancer; Oncology; Confidence interval; Metastasis; Adverse effect; Cancer; Immunotherapy","authors":[{"name":"Aaron S. Mansfield","is_ca":false},{"name":"Roy S. Herbst","is_ca":false},{"name":"Gilberto de Castro","is_ca":false},{"name":"Rina Hui","is_ca":false},{"name":"Nir Peled","is_ca":false},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Miyako Satouchi","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Andrew Robinson","is_ca":true},{"name":"Ayman Samkari","is_ca":false},{"name":"Bilal Piperdi","is_ca":false},{"name":"Victoria Ebiana","is_ca":false},{"name":"Jianxin Lin","is_ca":false},{"name":"Tony Mok","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04276317074613412,"gpt":0.4012464907436726,"spread":0.3584833199975385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00884251,0.00102782,0.003096439,0.001439743,0.0002212742,0.001255743,0.0006263324,0.0006502966,0.001154781],"category_scores_gemma":[0.005892787,0.0004826049,0.008593326,0.001848704,0.0002720654,0.0006683984,0.0007966001,0.0005162332,0.000167362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005180733,"about_ca_system_score_gemma":0.0004915168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008268152,"about_ca_topic_score_gemma":0.001325055,"domain_scores_codex":[0.9948153,0.002326135,0.0009993761,0.00113372,0.0005434309,0.000182052],"domain_scores_gemma":[0.9949741,0.001878694,0.002135825,0.0004520086,0.0003641626,0.0001951996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07299773,0.0001755557,0.5524677,0.005079383,0.3361805,0.0002093443,0.0001244673,0.002297739,0.003504378,0.0001257582,0.001032495,0.02580499],"study_design_scores_gemma":[0.006249066,0.008472857,0.7221637,0.0005807694,0.2537423,0.0006335286,0.0001778356,0.002386137,0.001662827,0.0003433237,0.003499231,0.00008839732],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9333875,0.05932011,0.001223488,0.0001232497,0.0000960318,0.0001590908,0.004788073,0.00002791967,0.0008746059],"genre_scores_gemma":[0.9931479,0.003189484,0.0003146227,0.00009399939,0.00006734549,0.0001239373,0.002907065,0.000008391467,0.0001471571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00884251,"threshold_uncertainty_score":0.04676425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308522396","doi":"10.1016/j.jtocrr.2022.100431","title":"Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Merck Sharp and Dohme; EMD Serono; Astellas Pharma; Chugai Pharmaceutical; Seagen; Mirati Therapeutics; National Cancer Institute; Genomic Health; Genentech; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celgene; Pfizer","keywords":"Pembrolizumab; Medicine; Internal medicine; KRAS; Oncology; Hazard ratio; Chemotherapy; Confidence interval; Cancer; Immunotherapy; Colorectal cancer","authors":[{"name":"Marina Chiara Garassino","is_ca":false},{"name":"Shirish M. Gadgeel","is_ca":false},{"name":"Silvia Novello","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Enriqueta Felip","is_ca":false},{"name":"Giovanna Speranza","is_ca":true},{"name":"Rina Hui","is_ca":false},{"name":"Edward B. Garon","is_ca":false},{"name":"Hidehito Horinouchi","is_ca":false},{"name":"Shunichi Sugawara","is_ca":false},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Răzvan Cristescu","is_ca":false},{"name":"Deepti Aurora-Garg","is_ca":false},{"name":"Andrey Loboda","is_ca":false},{"name":"Jared Lunceford","is_ca":false},{"name":"Julie Kobie","is_ca":false},{"name":"Mark Ayers","is_ca":false},{"name":"Bilal Piperdi","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Luis Paz‐Ares","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1407009378247309,"gpt":0.4856435322096953,"spread":0.3449425943849644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001323029,0.0001633091,0.0003764828,0.0002115083,0.0001782436,0.0004323756,0.0002161247,0.0002377486,0.001853065],"category_scores_gemma":[0.00232619,0.0001114316,0.0004175448,0.0002629769,0.0001986674,0.000409668,0.0002554135,0.0003968607,0.0001155783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003604732,"about_ca_system_score_gemma":0.0002080691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004780194,"about_ca_topic_score_gemma":0.001131329,"domain_scores_codex":[0.9992933,0.0002271759,0.00007887453,0.0001809766,0.0001455972,0.00007401433],"domain_scores_gemma":[0.9986406,0.0003869672,0.0006903306,0.00006842073,0.00005781396,0.0001557587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05115173,0.0003984155,0.9105125,0.0001715161,0.001443145,0.00009192213,0.00006414997,0.0007213074,0.007601458,0.0001130912,0.0004611199,0.0272696],"study_design_scores_gemma":[0.0004013923,0.004806424,0.9914363,0.00002554532,0.0004396345,0.0001757559,0.00004107153,0.0009292582,0.00103199,0.000120264,0.0005847825,0.000007436153],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983966,0.0007042092,0.0001059469,0.00004528894,0.000006235968,0.00001872939,0.0003022219,0.00000328179,0.000417599],"genre_scores_gemma":[0.999401,0.00009410184,0.00005823396,0.00002691806,0.000009408099,0.0000202493,0.0002596657,0.000001022712,0.0001295554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001853065,"threshold_uncertainty_score":0.00699693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3211244077","doi":"10.1016/j.jtocrr.2021.100249","title":"A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Atezolizumab; Medicine; Etoposide; Hazard ratio; Oncology; Internal medicine; Chemotherapy; Carboplatin; Confidence interval; Cisplatin; Cancer; Pembrolizumab; Immunotherapy","authors":[{"name":"A. Elegbede","is_ca":true},{"name":"A.J. Gibson","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"D. Gwyn Bebb","is_ca":true},{"name":"Aliyah Pabani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1270375563583288,"gpt":0.4785684825184646,"spread":0.3515309261601359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001217425,0.0001943443,0.000383119,0.0004199641,0.0006272428,0.0007064083,0.0003455311,0.0003051269,0.0008219003],"category_scores_gemma":[0.00388467,0.0001414204,0.0004333189,0.000989256,0.0004405603,0.0002762751,0.0004944446,0.0002927629,0.00008557632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008222648,"about_ca_system_score_gemma":0.007616329,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.435451,"about_ca_topic_score_gemma":0.523834,"domain_scores_codex":[0.9990589,0.0003355572,0.00008449132,0.0001282702,0.0002279004,0.0001648706],"domain_scores_gemma":[0.9967687,0.0005921588,0.0009864658,0.0001027235,0.0008966208,0.0006533201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005234108,0.0006074129,0.9742128,0.0001712123,0.0002208123,0.0002847467,0.0002638066,0.001292136,0.0006586093,0.00006755869,0.0005072524,0.0164796],"study_design_scores_gemma":[0.0007706276,0.004563176,0.9897845,0.00004611836,0.0001768275,0.0003854643,0.0006206874,0.001826317,0.0003307084,0.00003344489,0.001439377,0.00002273739],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985381,0.0002791395,0.0000544435,0.0000893695,0.000002404502,0.00009706455,0.0005370501,0.000003499418,0.0003989216],"genre_scores_gemma":[0.9988224,0.0002189419,0.0001959088,0.00006971281,0.000008823537,0.00003300923,0.0005516964,0.000001115112,0.00009837356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.564549,"threshold_uncertainty_score":0.8658329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386954645","doi":"10.1016/j.jtocrr.2023.100580","title":"Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Meta-analysis; Hazard ratio; Confidence interval; Internal medicine; Grading (engineering); Random effects model; Data extraction; MEDLINE","authors":[{"name":"Gilberto de Castro","is_ca":false},{"name":"Fabiano Hahn Souza","is_ca":false},{"name":"Júlia Lima","is_ca":false},{"name":"Luis Pedro Bernardi","is_ca":false},{"name":"Carlos Henrique Andrade Teixeira","is_ca":false},{"name":"Gustavo Faibischew Prado","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5955770920631436,"gpt":0.6212303727667053,"spread":0.02565328070356176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01676785,0.002278411,0.01579365,0.006262904,0.0005629615,0.003190582,0.001966724,0.002032151,0.003765997],"category_scores_gemma":[0.04744307,0.00135873,0.03307326,0.007163443,0.0007542968,0.001727687,0.001436871,0.001684761,0.000291392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002879773,"about_ca_system_score_gemma":0.00441315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007345339,"about_ca_topic_score_gemma":0.01405376,"domain_scores_codex":[0.9871317,0.006895299,0.00339558,0.001078405,0.001172566,0.0003264179],"domain_scores_gemma":[0.9713284,0.02239531,0.004067968,0.0006590943,0.001276684,0.0002724212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001236732,0.00002985366,0.004277356,0.4751464,0.5022679,0.00009401477,0.00007771445,0.0005254199,0.0001142368,0.0001525692,0.0006398274,0.01543801],"study_design_scores_gemma":[0.0004783722,0.0002168184,0.003905789,0.05646029,0.9366183,0.00007703411,0.00004298779,0.0002341272,0.00008004644,0.000244422,0.001620735,0.00002111135],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002853216,0.9954486,0.0004645926,0.000250067,0.0001227641,0.0002767074,0.0003571269,0.00001892891,0.0002078953],"genre_scores_gemma":[0.1157501,0.8788037,0.002340031,0.0007495476,0.0002833178,0.001212751,0.0006206038,0.00002481908,0.0002151434],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01676785,"threshold_uncertainty_score":0.08867788,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4321793664","doi":"10.1016/j.jtocrr.2023.100482","title":"Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Performance status; Pembrolizumab; Internal medicine; Nivolumab; Emergency department; Oncology; Immunotherapy; Cancer; Nursing","authors":[{"name":"Daniel E. Meyers","is_ca":true},{"name":"Meghann Pasternak","is_ca":true},{"name":"Samantha Dolter","is_ca":true},{"name":"Heidi A.I. Grosjean","is_ca":true},{"name":"Chloe Lim","is_ca":true},{"name":"Igor Stukalin","is_ca":true},{"name":"Siddhartha Goutam","is_ca":true},{"name":"Vishal Navani","is_ca":true},{"name":"Daniel Yick Chin Heng","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Don Morris","is_ca":true},{"name":"Aliyah Pabani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1030508635146237,"gpt":0.4667007910321048,"spread":0.363649927517481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007646887,0.0001397999,0.00018552,0.0003912223,0.0002361716,0.0005673773,0.0002694368,0.0002670405,0.001123121],"category_scores_gemma":[0.002612579,0.00008056553,0.0003447141,0.0006553456,0.0003064543,0.0002748883,0.0003108262,0.0004690883,0.00008932941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008707967,"about_ca_system_score_gemma":0.0007361142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01157651,"about_ca_topic_score_gemma":0.02320635,"domain_scores_codex":[0.9995832,0.0001373338,0.00003956828,0.00005615179,0.0001043378,0.00007939649],"domain_scores_gemma":[0.9980153,0.0004193712,0.0009791408,0.00005672182,0.0001428547,0.0003865277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001137685,0.00001997138,0.99852,0.000006942571,0.0000482161,0.0000137369,0.000009883083,0.00008062358,0.00003309397,0.00001020453,0.00008090672,0.001062615],"study_design_scores_gemma":[0.000006202188,0.00006856445,0.9995079,0.000005758921,0.00002078574,0.00004074741,0.00003186166,0.0002030849,0.0000201474,0.00001506917,0.0000783999,0.000001414416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982514,0.0006024561,0.00003182707,0.0001826529,0.000005451704,0.000005597485,0.0004613611,0.000002003623,0.0004573394],"genre_scores_gemma":[0.9995244,0.00009772486,0.00002090725,0.00002941195,0.000008360274,0.000002615151,0.0002808927,3.759101e-7,0.00003541963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01157651,"threshold_uncertainty_score":0.02301824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3115817852","doi":"10.1016/j.jtocrr.2020.100137","title":"Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria—Reducing Race Disparities","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Lung cancer screening; Cohort; Lung cancer; Demography; Population; Retrospective cohort study; Ethnic group; Task force; Race (biology); Cohort study; Cancer; Gerontology; Internal medicine; Environmental health","authors":[{"name":"Mary Pasquinelli","is_ca":false},{"name":"Martin C. Tammemägi","is_ca":true},{"name":"Kevin L. Kovitz","is_ca":false},{"name":"Marianne L. Durham","is_ca":false},{"name":"Zanë Deliu","is_ca":false},{"name":"Kayleigh Rygalski","is_ca":false},{"name":"Li Liu","is_ca":false},{"name":"Matthew Koshy","is_ca":false},{"name":"Patricia W. Finn","is_ca":false},{"name":"Lawrence Feldman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0770495536566536,"gpt":0.4782571124725352,"spread":0.4012075588158816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02377087,0.001413811,0.001375449,0.001288297,0.0005975363,0.00249125,0.001587642,0.001509149,0.01079094],"category_scores_gemma":[0.06055025,0.0004026759,0.002462685,0.0008636024,0.0002726816,0.001285852,0.001387455,0.00185032,0.001514789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001546441,"about_ca_system_score_gemma":0.003492883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03111786,"about_ca_topic_score_gemma":0.0104886,"domain_scores_codex":[0.9928067,0.005144201,0.0002473407,0.0008510624,0.0006254763,0.0003251533],"domain_scores_gemma":[0.9769518,0.01749604,0.001195551,0.0009700864,0.002691359,0.0006951787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.008364412,0.001935077,0.3638759,0.0007425073,0.002982396,0.0003659595,0.0002570691,0.1861038,0.0005088039,0.006865255,0.1441243,0.2838746],"study_design_scores_gemma":[0.001132873,0.001870043,0.04499702,0.0003182617,0.001099179,0.0001688786,0.0002697363,0.9346392,0.0006507825,0.006298753,0.00846348,0.00009180573],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7242206,0.01033164,0.1584264,0.03820446,0.005593994,0.002831022,0.02901248,0.003132732,0.0282466],"genre_scores_gemma":[0.9220454,0.001434731,0.04477524,0.003003081,0.00199693,0.001006879,0.01772248,0.0002549087,0.007760395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03111786,"threshold_uncertainty_score":0.1257139,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3091933145","doi":"10.1016/j.jtocrr.2020.100103","title":"JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Listeria monocytogenes in Food Safety","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"EMD Serono; Johnson and Johnson; Genentech; Astellas Pharma; Eisai; Daiichi-Sankyo; Pfizer; Incyte; Pharmaceuticals Bayer; Syndax Pharmaceuticals; Clovis Oncology; Bayer Fund; AstraZeneca; Canadian Asian Studies Association; Novocure; Exelixis; Takeda Pharmaceuticals U.S.A.; Spectrum Pharmaceuticals; Merck; University of Michigan; AbbVie; Roche; Novartis; Celgene; Eli Lilly and Company; Bristol-Myers Squibb; Boehringer Ingelheim; Amgen","keywords":"Chills; Medicine; Nivolumab; Internal medicine; Gastroenterology; Combination therapy; Adverse effect; Immunotherapy; Phases of clinical research; Surgery; Cancer; Chemotherapy","authors":[{"name":"Julie R. Brahmer","is_ca":false},{"name":"Melissa L. Johnson","is_ca":false},{"name":"Manuel Cobo","is_ca":false},{"name":"Santiago Viteri","is_ca":false},{"name":"J. Coves Sarto","is_ca":false},{"name":"Ammar Sukari","is_ca":false},{"name":"Mark M. Awad","is_ca":false},{"name":"Ravi Salgia","is_ca":false},{"name":"Vali A. Papadimitrakopoulou","is_ca":false},{"name":"Arun Rajan","is_ca":false},{"name":"Nibedita Bandyopadhyay","is_ca":false},{"name":"Alicia J. Allred","is_ca":false},{"name":"Mark Wade","is_ca":false},{"name":"Gary Mason","is_ca":false},{"name":"Enrique Zudaire","is_ca":false},{"name":"Roland E. Knoblauch","is_ca":false},{"name":"Nicole L. Stone","is_ca":false},{"name":"Matthew V. Lorenzi","is_ca":false},{"name":"Raffit Hassan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.312419106822627,"gpt":0.4891006084337852,"spread":0.1766815016111582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001755756,0.0007911963,0.001176036,0.0002438607,0.0003093884,0.0006207612,0.0004799736,0.0007265087,0.001222114],"category_scores_gemma":[0.0004399884,0.00025985,0.0008089584,0.000213974,0.0004783465,0.0003797832,0.0002224149,0.001083752,0.0003733038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001133642,"about_ca_system_score_gemma":0.00140769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0016163,"about_ca_topic_score_gemma":0.00627214,"domain_scores_codex":[0.9996448,0.0001207556,0.00003130283,0.00006206709,0.00007576567,0.00006532195],"domain_scores_gemma":[0.9996276,0.00004434559,0.00007203274,0.00002101228,0.00005551786,0.0001794933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2393064,0.05407114,0.05148873,0.002903345,0.004907317,0.0006773424,0.0006149579,0.00314235,0.2205467,0.0003041491,0.009425674,0.412612],"study_design_scores_gemma":[0.2224674,0.5911852,0.1415997,0.0002612769,0.002982043,0.001271885,0.0002175549,0.002229178,0.0205169,0.0001511861,0.01701512,0.0001027186],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899113,0.007157262,0.0002831598,0.0003019828,0.000104069,0.0006193182,0.0004818059,0.00005171202,0.001089472],"genre_scores_gemma":[0.991154,0.003505925,0.0008875394,0.0008212422,0.0001026726,0.0003611345,0.002060426,0.00001509551,0.001091974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001755756,"threshold_uncertainty_score":0.00928545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4280525579","doi":"10.1016/j.jtocrr.2022.100340","title":"Automating Access to Real-World Evidence","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Pediatric Oncology Group; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; Open Society Institute; Roche","keywords":"Concordance; Artificial intelligence; Gold standard (test); Data extraction; Computer science; Medicine; Natural language processing; Data collection; Machine learning; MEDLINE; Internal medicine; Statistics","authors":[{"name":"Marie-Pier Gauthier","is_ca":true},{"name":"Jennifer Law","is_ca":true},{"name":"Lisa W. Le","is_ca":true},{"name":"Janice J.N. Li","is_ca":true},{"name":"Sajda Zahir","is_ca":true},{"name":"Sharon Nirmalakumar","is_ca":true},{"name":"Christopher Pettengell","is_ca":true},{"name":"Ryan Chu","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8253776973697489,"gpt":0.7123081539362991,"spread":0.1130695434334498,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0844216,0.001248118,0.002294837,0.02042711,0.001215281,0.01198073,0.003718393,0.001920878,0.009701011],"category_scores_gemma":[0.2979788,0.001449338,0.002879015,0.01104394,0.002339093,0.00780061,0.01058834,0.002442943,0.004760269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002765083,"about_ca_system_score_gemma":0.01336215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004889348,"about_ca_topic_score_gemma":0.006375594,"domain_scores_codex":[0.9061781,0.05066015,0.01631307,0.007681881,0.01791547,0.001251247],"domain_scores_gemma":[0.4802587,0.3881681,0.03560636,0.05715792,0.03649857,0.002310445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0005583429,0.0002134334,0.04386383,0.01099281,0.00119038,0.0008377203,0.00374489,0.004909696,0.004604802,0.009413064,0.03299594,0.8866752],"study_design_scores_gemma":[0.0006165238,0.0005556867,0.1233344,0.02332756,0.002206594,0.0050294,0.007200896,0.06104038,0.02533505,0.1797916,0.5708779,0.0006840365],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1153315,0.0359289,0.7282256,0.03187448,0.0009732358,0.006434509,0.02074196,0.01236441,0.0481254],"genre_scores_gemma":[0.2485907,0.01185476,0.7138814,0.004195291,0.0007581307,0.001984861,0.01518471,0.0009454901,0.002604578],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0844216,"threshold_uncertainty_score":0.4464694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318954097","doi":"10.1016/j.jtocrr.2023.100469","title":"Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Canadian Partnership Against Cancer; Public Health Ontario; University of Toronto; Women's College Hospital; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Partenariat Canadien Contre Le Cancer; Women's College Hospital","keywords":"Psychological intervention; Grey literature; Scopus; MEDLINE; Medicine; Health equity; Family medicine; Health care; Gerontology; Nursing; Public health; Political science","authors":[{"name":"Ambreen Sayani","is_ca":true},{"name":"Muhanad Ahmed Ali","is_ca":true},{"name":"Pooja Dey","is_ca":true},{"name":"Ann Marie Corrado","is_ca":true},{"name":"Carolyn Ziegler","is_ca":true},{"name":"Erika Nicholson","is_ca":true},{"name":"Aïsha Lofters","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3764621298431538,"gpt":0.6200331712581714,"spread":0.2435710414150176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04168361,0.002516646,0.006920319,0.01806951,0.001440919,0.006241788,0.002833341,0.005275954,0.005023809],"category_scores_gemma":[0.1471483,0.001541407,0.006636223,0.01361957,0.001848408,0.005067575,0.003744368,0.002572241,0.0004825311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01005543,"about_ca_system_score_gemma":0.03138414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007219665,"about_ca_topic_score_gemma":0.01224166,"domain_scores_codex":[0.9652222,0.01844718,0.008149873,0.001604472,0.005749437,0.000826804],"domain_scores_gemma":[0.9019619,0.08161449,0.008087762,0.001057912,0.006661535,0.0006164216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002020974,0.0001325722,0.0008103293,0.8163466,0.004351556,0.00008826195,0.0008703519,0.0004903626,0.0001588954,0.002850045,0.002596783,0.1711021],"study_design_scores_gemma":[0.0001407846,0.0001421482,0.001074127,0.9729433,0.01023377,0.00006561256,0.000399397,0.0001570543,0.0001455846,0.0007235421,0.0139579,0.00001687077],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001187776,0.991876,0.0008922474,0.00186796,0.0004994941,0.001999514,0.0001769905,0.00001570184,0.001484201],"genre_scores_gemma":[0.01666469,0.9744937,0.002908487,0.001633883,0.0002939689,0.003614602,0.0001585685,0.000007773671,0.0002243661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04168361,"threshold_uncertainty_score":0.2204466,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135563856","doi":"10.1016/j.jtocrr.2021.100157","title":"Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"Boehringer Ingelheim; Pfizer Canada; AbbVie; Merck; AstraZeneca; Novartis; Pfizer; Takeda Pharmaceutical Company; Bristol-Myers Squibb","keywords":"Crizotinib; Medicine; Internal medicine; Alectinib; ALK inhibitor; Anaplastic lymphoma kinase; Oncology; Ceritinib; Lung cancer; Context (archaeology); Population; Hazard ratio; Brain metastasis; Gastroenterology; Cancer; Metastasis; Confidence interval; Biology","authors":[{"name":"A.J. Gibson","is_ca":true},{"name":"Adrian Box","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"A. Elegbede","is_ca":true},{"name":"Desirée Hao","is_ca":true},{"name":"Randeep Sangha","is_ca":true},{"name":"D. Gwyn Bebb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05235902605818746,"gpt":0.4677355556769182,"spread":0.4153765296187307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007263193,0.0003181888,0.0002750228,0.001169468,0.000590943,0.00114122,0.0007008897,0.0004975458,0.002179948],"category_scores_gemma":[0.002401677,0.0002687946,0.0005631018,0.002082072,0.0007162679,0.0005472072,0.0006874756,0.0006251706,0.0002166541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003612725,"about_ca_system_score_gemma":0.002976728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3839788,"about_ca_topic_score_gemma":0.4986843,"domain_scores_codex":[0.9991043,0.0000976052,0.0000956667,0.0002019299,0.0002404432,0.0002600341],"domain_scores_gemma":[0.9980137,0.0001960947,0.0009157929,0.0001605993,0.0003524743,0.0003612079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001729079,0.00001284475,0.9984426,0.00001209695,0.00008551475,0.00003516309,0.00003517446,0.0001351644,0.00004517907,0.00002762845,0.0003836562,0.0006120633],"study_design_scores_gemma":[0.00001775606,0.00005196458,0.9984773,0.00001537838,0.00006368461,0.0001806898,0.0003147938,0.0003017758,0.00003576893,0.00002950462,0.0005024921,0.000008751312],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918697,0.0004874296,0.0001167005,0.00008013834,0.00001116825,0.00002430242,0.006630868,0.000007561121,0.0007721601],"genre_scores_gemma":[0.9955948,0.0001144551,0.00004792822,0.0000365753,0.000008685134,0.00001216178,0.003984145,0.000002115748,0.0001992047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3839788,"threshold_uncertainty_score":0.7634876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225994592","doi":"10.1016/j.jtocrr.2022.100324","title":"Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Merck Sharp and Dohme; Roche; Novartis; Amgen; Pfizer; Les Laboratories Pierre Fabre; Novartis Pharmaceuticals Corporation; AstraZeneca; Takeda Pharmaceutical Company; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dabrafenib; Hazard ratio; Medicine; Trametinib; Internal medicine; Oncology; Confidence interval; Proportional hazards model; Vemurafenib; Cancer","authors":[{"name":"Bruce E. Johnson","is_ca":false},{"name":"Christina S. Baik","is_ca":false},{"name":"Julien Mazières","is_ca":false},{"name":"Harry J.M. Groen","is_ca":false},{"name":"Barbara Melosky","is_ca":true},{"name":"Jürgen Wolf","is_ca":false},{"name":"Fatemeh Asad Zadeh Vosta Kolaei","is_ca":false},{"name":"Wen-Hsing Wu","is_ca":false},{"name":"Stefanie Knoll","is_ca":false},{"name":"Meryem Ktiouet Dawson","is_ca":false},{"name":"Adam Johns","is_ca":false},{"name":"David Planchard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07276526832441786,"gpt":0.4439244341244604,"spread":0.3711591658000425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00411096,0.0009735868,0.001604777,0.0003416367,0.0002862943,0.00127452,0.0006113718,0.001055529,0.001982264],"category_scores_gemma":[0.003870459,0.0003097072,0.002491929,0.0003156021,0.0007685804,0.0009575297,0.0004324791,0.00186032,0.0002726293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001376839,"about_ca_system_score_gemma":0.001064805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005230411,"about_ca_topic_score_gemma":0.001284898,"domain_scores_codex":[0.9980591,0.001271024,0.0001558697,0.000245954,0.0001204107,0.0001475829],"domain_scores_gemma":[0.998405,0.0004021381,0.0005310907,0.0001111747,0.0001123929,0.0004382644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9648887,0.004338646,0.004037527,0.0005162196,0.002453786,0.0000359746,0.00005170072,0.001751348,0.001184384,0.0001166676,0.0003835754,0.02024141],"study_design_scores_gemma":[0.7297904,0.2375709,0.02408056,0.000124922,0.002642281,0.0001461915,0.00006855882,0.003025631,0.0008672936,0.0004007738,0.001239863,0.00004250168],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942684,0.003187392,0.0002532406,0.0004827832,0.0002419049,0.0006001479,0.0002494987,0.00001844055,0.0006980898],"genre_scores_gemma":[0.9975,0.0006628746,0.0003425557,0.0001995246,0.0001208974,0.0005583772,0.0002927247,0.000002734374,0.0003203778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00411096,"threshold_uncertainty_score":0.02174109,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205902408","doi":"10.1016/j.jtocrr.2022.100276","title":"Performance of an RNA-Based Next-Generation Sequencing Assay for Combined Detection of Clinically Actionable Fusions and Hotspot Mutations in NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Pfizer Canada; AstraZeneca; Bayer; Novartis; Pfizer; Eli Lilly and Company","keywords":"Computational biology; DNA sequencing; RNA; Multiplex; Housekeeping gene; Biology; Gene; Bioinformatics; Genetics; Gene expression","authors":[{"name":"Patrice Desmeules","is_ca":true},{"name":"Dominique K. Boudreau","is_ca":true},{"name":"Nathalie Bastien","is_ca":true},{"name":"Marie‐Chloé Boulanger","is_ca":true},{"name":"Yohan Bossé","is_ca":true},{"name":"Philippe Joubert","is_ca":true},{"name":"Christian Couture","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1285371054467086,"gpt":0.4045420364913926,"spread":0.276004931044684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100156,0.0003266466,0.0002316354,0.0005239677,0.0001779794,0.0004197717,0.0002289195,0.0003824187,0.0006203392],"category_scores_gemma":[0.0010536,0.0001857011,0.0001924094,0.0002061442,0.0001926278,0.0001430405,0.0001927785,0.0001866588,0.0003173914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000248832,"about_ca_system_score_gemma":0.000286972,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006186034,"about_ca_topic_score_gemma":0.001155913,"domain_scores_codex":[0.9992761,0.0001584185,0.00004643459,0.0002314445,0.0002356778,0.00005202123],"domain_scores_gemma":[0.9996432,0.0001630955,0.00006134079,0.00003446582,0.00007612597,0.00002169712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002959124,0.00006257954,0.02067816,0.00005116788,0.00004362665,0.00008344492,0.00008122411,0.001024324,0.9626461,0.00006307433,0.0001032691,0.01486702],"study_design_scores_gemma":[0.00002306074,0.001094199,0.07206257,0.00001881506,0.0001272919,0.001124504,0.000064501,0.0136018,0.9105092,0.0001130608,0.001234586,0.0000264224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.9737018,0.0009232851,0.02344419,0.00005189486,0.00001108233,0.00008960686,0.0006979774,0.0001969401,0.0008832611],"genre_scores_gemma":[0.963856,0.0002773691,0.03397809,0.00007115689,0.000008501346,0.0001031342,0.00104506,0.00001698661,0.000643581],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.001100156,"threshold_uncertainty_score":0.005818248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313856340","doi":"10.1016/j.jtocrr.2022.100460","title":"Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Systemic therapy; Targeted therapy; Medicine; Oncology; Immune checkpoint; Mutation; Immune system; Cancer research; Internal medicine; Immunotherapy; Immunology; Biology; Cancer; Genetics; Gene","authors":[{"name":"Amanda J.W. Gibson","is_ca":true},{"name":"Aliyah Pabani","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"Guillermo Martos","is_ca":true},{"name":"Winson Y. Cheung","is_ca":true},{"name":"Vishal Navani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05075850538365254,"gpt":0.391417087290026,"spread":0.3406585819063734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001854898,0.00009259085,0.0002956844,0.0006440418,0.0001440045,0.0005348091,0.0002444912,0.0002952371,0.0007864367],"category_scores_gemma":[0.005940737,0.00009387168,0.0003959055,0.000907152,0.0002101432,0.0004809737,0.0002969704,0.0002385456,0.0001212718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000762129,"about_ca_system_score_gemma":0.0003970337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00149461,"about_ca_topic_score_gemma":0.00317855,"domain_scores_codex":[0.9978582,0.0008956915,0.0004185856,0.0004010041,0.0003075959,0.0001188883],"domain_scores_gemma":[0.9935679,0.001773561,0.003810131,0.000260783,0.000338319,0.0002492869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008485495,0.00004840686,0.9865023,0.00005347787,0.0002055947,0.00007282777,0.00005052485,0.0006168729,0.0003665378,0.00004454229,0.0001850087,0.01100532],"study_design_scores_gemma":[0.0000269805,0.0002682524,0.9973602,0.00002106591,0.00005528052,0.000418331,0.0001171406,0.0008840389,0.0002624485,0.00007563262,0.0005032005,0.000007527703],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971111,0.001314024,0.0001827337,0.0001069475,0.000004176565,0.00001337529,0.0007939267,0.000004259383,0.0004693582],"genre_scores_gemma":[0.9990055,0.0001783984,0.0001068053,0.00002342595,0.000005158227,0.000009494953,0.0006316871,0.000001715561,0.00003783871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001854898,"threshold_uncertainty_score":0.009809732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4293565846","doi":"10.1016/j.jtocrr.2022.100400","title":"BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; Alberta Health Services; McMaster University; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"Genentech; Astellas Pharma; Regeneron Pharmaceuticals; Ipsen; BeiGene; Merck KGaA; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Adverse effect; Combination therapy; Internal medicine; Pharmacokinetics; Refractory (planetary science); Oncology; Confidence interval; Progression-free survival; Phases of clinical research; Clinical endpoint; Gastroenterology; Pharmacology; Chemotherapy; Immunotherapy; Cancer; Clinical trial","authors":[{"name":"Quincy S. Chu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Veerle Surmont","is_ca":false},{"name":"Carla van Herpen","is_ca":false},{"name":"Anne Sibille","is_ca":false},{"name":"Ben Markman","is_ca":false},{"name":"Stephen Clarke","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Mirelis Acosta Rivera","is_ca":false},{"name":"Vladimir Andelkovic","is_ca":false},{"name":"Charles M. Rudin","is_ca":false},{"name":"Stephanie Snow","is_ca":true},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Michael Sanatani","is_ca":false},{"name":"Hongxia Lin","is_ca":false},{"name":"Kinjal Sanghavi","is_ca":false},{"name":"Sarah Tannenbaum-Dvir","is_ca":false},{"name":"Paul Basciano","is_ca":false},{"name":"Deanne Lathers","is_ca":false},{"name":"Katarzyna Urbańska","is_ca":false},{"name":"Georgia Kollia","is_ca":false},{"name":"Chunsheng He","is_ca":false},{"name":"Andrew DiPiero","is_ca":false},{"name":"Yu Liu","is_ca":false},{"name":"Neal Ready","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07985497471285384,"gpt":0.466754628081248,"spread":0.3868996533683942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001446367,0.001319939,0.002214739,0.0006271779,0.0003344998,0.0008595682,0.0006721987,0.001091898,0.002169627],"category_scores_gemma":[0.0006180949,0.0004503237,0.001568727,0.0005355026,0.0006435884,0.0007878397,0.0002277059,0.001908117,0.0008755716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008429567,"about_ca_system_score_gemma":0.0009339222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00110967,"about_ca_topic_score_gemma":0.003426117,"domain_scores_codex":[0.99963,0.00015012,0.00003456608,0.00006348339,0.00006046327,0.00006147954],"domain_scores_gemma":[0.9995785,0.00007009904,0.00008099442,0.00002797398,0.00004436287,0.0001980319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4964247,0.06107271,0.01489143,0.002921629,0.004847159,0.0005154807,0.0005264254,0.002777706,0.1106656,0.0001970354,0.007101568,0.2980585],"study_design_scores_gemma":[0.3903529,0.5460473,0.04200627,0.0001998401,0.002433585,0.0009199778,0.0001401286,0.001938657,0.01085091,0.0001747246,0.004860912,0.00007474721],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902799,0.006827983,0.0002042148,0.0002659615,0.00008269253,0.0005494679,0.0006309801,0.0000783366,0.00108051],"genre_scores_gemma":[0.9884794,0.006198359,0.0007199969,0.0006489926,0.0001693462,0.0005070756,0.001909451,0.00003966563,0.001327822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002214739,"threshold_uncertainty_score":0.007649183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4288969861","doi":"10.1016/j.jtocrr.2022.100385","title":"Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Genentech; PharmaMar; Daiichi-Sankyo; G1 Therapeutics; EMD Serono; Otsuka America; Ribon Therapeutics; Takeda Oncology; Mirati Therapeutics; Bayer Fund; Abbott Laboratories; Clovis Oncology; National Center for Advancing Translational Sciences; Johnson and Johnson; Les Laboratories Pierre Fabre; Merck Sharp and Dohme; Takeda Pharmaceuticals U.S.A.; Ipsen Biopharmaceuticals; Novartis; Celgene; Unum Therapeutics; Merck KGaA; Servier; Gilead Sciences; Sanofi; Roche; Yuhan; Merck; GlaxoSmithKline; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; Canadian Asian Studies Association; AstraZeneca; Aerie Pharmaceuticals; Pfizer; Ariad Pharmaceuticals; Boehringer Ingelheim; Amgen; Regeneron Pharmaceuticals","keywords":"Crizotinib; Refractory (planetary science); Medicine; Phase (matter); Term (time); Internal medicine; Oncology; Phases of clinical research; Clinical trial; Lung cancer; Materials science; Chemistry; Physics","authors":[{"name":"Scott Gettinger","is_ca":false},{"name":"Rudolf M. Huber","is_ca":false},{"name":"Dong‐Wan Kim","is_ca":false},{"name":"Lyudmila Bazhenova","is_ca":false},{"name":"Karin Holmskov Hansen","is_ca":false},{"name":"Marcello Tiseo","is_ca":false},{"name":"Corey J. Langer","is_ca":false},{"name":"Luis G. Paz-Ares Rodríguez","is_ca":false},{"name":"Howard West","is_ca":false},{"name":"Karen L. Reckamp","is_ca":false},{"name":"Glen J. Weiss","is_ca":false},{"name":"Egbert F. Smit","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Sang‐We Kim","is_ca":false},{"name":"Myung‐Ju Ahn","is_ca":false},{"name":"Edward S. Kim","is_ca":false},{"name":"Harry J.M. Groen","is_ca":false},{"name":"Joanna Pye","is_ca":false},{"name":"Yuyin Liu","is_ca":false},{"name":"Pingkuan Zhang","is_ca":false},{"name":"Florin Vranceanu","is_ca":false},{"name":"D. Ross Camidge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2062120733192719,"gpt":0.5581480541043659,"spread":0.351935980785094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007367743,0.0008714258,0.001265297,0.0003064093,0.0004211895,0.001287741,0.0006527838,0.0008138524,0.001975172],"category_scores_gemma":[0.003448289,0.0003172697,0.001523748,0.0004357188,0.0005482268,0.0007653543,0.0003237024,0.001788879,0.0004455749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051447,"about_ca_system_score_gemma":0.001100769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009526387,"about_ca_topic_score_gemma":0.002689163,"domain_scores_codex":[0.9982283,0.0011136,0.0001582723,0.0001525069,0.0001994647,0.0001479974],"domain_scores_gemma":[0.9974985,0.0006410815,0.001040666,0.0001637713,0.0002807083,0.0003752111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.677507,0.008391108,0.0310702,0.002837934,0.007466805,0.0002402843,0.0002678424,0.002106744,0.02479923,0.0003784178,0.01042984,0.2345046],"study_design_scores_gemma":[0.5802806,0.2555479,0.1166198,0.0006170815,0.008597289,0.001002806,0.0001640727,0.001475465,0.01111945,0.0007817338,0.02363191,0.0001620783],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9135605,0.07596844,0.0007542682,0.00191267,0.0002517009,0.0008534036,0.003001581,0.0001085898,0.003589013],"genre_scores_gemma":[0.9751764,0.01545528,0.001196137,0.001637638,0.0004307836,0.0006466794,0.004224336,0.00002958679,0.001203047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007367743,"threshold_uncertainty_score":0.03896481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310859181","doi":"10.1016/j.jtocrr.2022.100444","title":"First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Merck Sharp and Dohme; Ministère de la Santé et des Services sociaux; Merck","keywords":"Pembrolizumab; Medicine; Carboplatin; Internal medicine; Chemotherapy; Oncology; Confidence interval; Retrospective cohort study; Cancer; Immunotherapy; Cisplatin","authors":[{"name":"Stephen V. Liu","is_ca":false},{"name":"Pragya Rai","is_ca":false},{"name":"Dong Wang","is_ca":false},{"name":"Xiaohan Hu","is_ca":false},{"name":"Paul Schwarzenberger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1758482435059359,"gpt":0.5244882499617058,"spread":0.3486400064557699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008555872,0.0001703813,0.0001881541,0.0006045598,0.0003564265,0.0006777605,0.0002848249,0.0002661412,0.001211756],"category_scores_gemma":[0.002819742,0.0001854491,0.0002585674,0.001243077,0.0002096499,0.0005714366,0.0005619306,0.0003196214,0.0002431758],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009792499,"about_ca_system_score_gemma":0.000662252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008602858,"about_ca_topic_score_gemma":0.01374007,"domain_scores_codex":[0.999206,0.0002185934,0.0001328611,0.0001953639,0.0001668868,0.00008040866],"domain_scores_gemma":[0.9958793,0.0003580934,0.002961364,0.0001604891,0.0003001438,0.0003405762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007806333,0.00002738222,0.9978667,0.00001116954,0.00002998454,0.00003483044,0.00005466121,0.00006887934,0.00005379822,0.000009490616,0.0001617194,0.001603213],"study_design_scores_gemma":[0.00002100259,0.0001655153,0.9976183,0.00001885123,0.00004308132,0.0004389214,0.0002247498,0.000341332,0.0001984682,0.00002489691,0.0008994152,0.000005374952],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973265,0.0003070836,0.00009856582,0.0000773514,0.00000303044,0.00002139097,0.001718074,0.000004910515,0.0004431327],"genre_scores_gemma":[0.9973223,0.0001765318,0.0001632224,0.00004549768,0.000009127913,0.00002377278,0.002100319,0.000002055492,0.0001572314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008602858,"threshold_uncertainty_score":0.01710558,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3208513157","doi":"10.1016/j.jtocrr.2021.100251","title":"Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Takeda Canada; Bristol-Myers Squibb Canada; EMD Serono; Amgen; Boehringer Ingelheim; Meso Scale Diagnostics; Sanofi; Roche; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Hazard ratio; Stage (stratigraphy); Adverse effect; Incidence (geometry); Chemotherapy; Oncology; Cancer; Confidence interval; Immunotherapy","authors":[{"name":"Sally C. M. Lau","is_ca":true},{"name":"Malcolm Ryan","is_ca":true},{"name":"Jessica Weiss","is_ca":true},{"name":"Aline Fusco Fares","is_ca":false},{"name":"Miguel García-Pardo","is_ca":true},{"name":"Sabine Schmid","is_ca":true},{"name":"Shelley Kuang","is_ca":true},{"name":"Deirdre Kelly","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"B. C. John Cho","is_ca":true},{"name":"A. Sun","is_ca":true},{"name":"Srinivas Raman","is_ca":true},{"name":"Andrew Hope","is_ca":true},{"name":"Meredith Giuliani","is_ca":true},{"name":"Benjamin H. Lok","is_ca":true},{"name":"Andrea Bezjak","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0722457016137158,"gpt":0.4211569068315087,"spread":0.348911205217793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003641651,0.00008315493,0.0002641568,0.0001066777,0.000089837,0.0002036162,0.0001011781,0.00009645423,0.0004181831],"category_scores_gemma":[0.0007224383,0.00003881882,0.0002104434,0.0001673799,0.0001069786,0.0001618404,0.00009733012,0.0001719099,0.00006869039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003172377,"about_ca_system_score_gemma":0.0002576883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006338758,"about_ca_topic_score_gemma":0.002158284,"domain_scores_codex":[0.9999099,0.00002395918,0.00001232128,0.00001797183,0.00002516957,0.00001080156],"domain_scores_gemma":[0.9996364,0.00008503778,0.0001705977,0.00002256386,0.00002758167,0.00005779941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02434155,0.0006465393,0.6618378,0.0003740951,0.0007286401,0.0003818491,0.000134212,0.0005508436,0.01547066,0.00009705615,0.0008175139,0.2946191],"study_design_scores_gemma":[0.001367897,0.01565501,0.9687566,0.0001182701,0.0007400665,0.002133309,0.00009314209,0.001192798,0.005849831,0.0001114751,0.003969907,0.00001161933],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994142,0.005065672,0.0001077656,0.0000529239,0.000008152245,0.00001271732,0.00008355179,0.000004902151,0.0005222789],"genre_scores_gemma":[0.9984676,0.001090969,0.0001451726,0.00004622045,0.00001682102,0.000006349312,0.0001226525,0.000001302276,0.0001029754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006338758,"threshold_uncertainty_score":0.002301693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389839591","doi":"10.1016/j.jtocrr.2023.100623","title":"Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Genentech; National Institutes of Health; Mirati Therapeutics; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Damon Runyon Cancer Research Foundation; LUNGevity Foundation; Computer Modelling Group; Amgen; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; V Foundation for Cancer Research","keywords":"Profiling (computer programming); Mutant; Transformation (genetics); Cancer research; Oncology; Computational biology; Medicine; Biology; Computer science; Gene; Genetics","authors":[{"name":"Bingnan Zhang","is_ca":false},{"name":"Whitney E. Lewis","is_ca":false},{"name":"C. Allison Stewart","is_ca":false},{"name":"Benjamin B. Morris","is_ca":false},{"name":"Luisa M. Solis","is_ca":false},{"name":"Alejandra G. Serrano","is_ca":false},{"name":"Yuanxin Xi","is_ca":false},{"name":"Qi Wang","is_ca":false},{"name":"Elyse R. Lopez","is_ca":false},{"name":"Kyle Concannon","is_ca":false},{"name":"Simon Heeke","is_ca":false},{"name":"Ximing Tang","is_ca":false},{"name":"Gabriela Raso","is_ca":false},{"name":"Robert J. Cardnell","is_ca":false},{"name":"Natalie I. Vokes","is_ca":false},{"name":"George Blumenschein","is_ca":false},{"name":"Yasir Y. Elamin","is_ca":false},{"name":"Frank Fosella","is_ca":false},{"name":"Anne S. Tsao","is_ca":false},{"name":"Ferdinandos Skoulidis","is_ca":false},{"name":"Celyne Bueno Hume","is_ca":false},{"name":"Koji Sasak","is_ca":false},{"name":"Jeff Lewis","is_ca":false},{"name":"Waree Rinsurongkawong","is_ca":false},{"name":"Vadeerat Rinsurongkawong","is_ca":false},{"name":"Hai T. Tran","is_ca":false},{"name":"Jianjun Zhang","is_ca":false},{"name":"Don L. Gibbons","is_ca":false},{"name":"Ara A. Vaporciyan","is_ca":false},{"name":"Jing Wang","is_ca":false},{"name":"Keunchil Park","is_ca":false},{"name":"John V. Heymach","is_ca":false},{"name":"Lauren A. Byers","is_ca":false},{"name":"Carl M. Gay","is_ca":false},{"name":"Xiuning Le","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1404393992648889,"gpt":0.4482286477040534,"spread":0.3077892484391644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005148199,0.0003288334,0.0003500509,0.000801225,0.0003475452,0.0009609262,0.0002629867,0.000571123,0.005023886],"category_scores_gemma":[0.0008220976,0.0001514007,0.0002239094,0.0006670627,0.0001872394,0.0003309181,0.0004111238,0.0004368428,0.002022983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003399831,"about_ca_system_score_gemma":0.0004821534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004531479,"about_ca_topic_score_gemma":0.0009325977,"domain_scores_codex":[0.9997116,0.00004059659,0.00003256038,0.00008560564,0.00007829504,0.00005139947],"domain_scores_gemma":[0.999194,0.0001312653,0.0001483235,0.00005996784,0.0002301654,0.0002364326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.002202727,0.0002701461,0.3734012,0.001224853,0.0002937909,0.01680312,0.0004664081,0.0005953709,0.1124507,0.0007673196,0.2317284,0.2597959],"study_design_scores_gemma":[0.0001142241,0.00125326,0.6390106,0.0002127203,0.0003664802,0.05889466,0.0007786449,0.001240967,0.03109156,0.0008937771,0.2660468,0.00009622535],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8628286,0.03993579,0.01043492,0.0152868,0.005645889,0.0005426205,0.04452401,0.001614056,0.01918724],"genre_scores_gemma":[0.9350532,0.01441443,0.005252355,0.002712343,0.005239313,0.000173245,0.02670089,0.000182355,0.01027194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005023886,"threshold_uncertainty_score":0.0168066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043913046","doi":"10.1016/j.jtocrr.2020.100078","title":"Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Actelion Pharmaceuticals; AstraZeneca","keywords":"Medicine; Pathological; Univariate analysis; Univariate; Cohort; Multivariate analysis; Radiology; Hyperplasia; Lung; Multivariate statistics; Internal medicine; Pathology","authors":[{"name":"Olga V. Sazonova","is_ca":true},{"name":"Venkata Manem","is_ca":true},{"name":"Chloé Béland","is_ca":true},{"name":"Marc-André Hamel","is_ca":true},{"name":"Yves Lacasse","is_ca":true},{"name":"Marie‐Hélène Lévesque","is_ca":true},{"name":"Michèle Orain","is_ca":true},{"name":"David Joubert","is_ca":true},{"name":"Steeve Provencher","is_ca":true},{"name":"David Simonyan","is_ca":true},{"name":"Philippe Joubert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1388772779288449,"gpt":0.4436086075436396,"spread":0.3047313296147947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01950625,0.0007913344,0.000805068,0.003285327,0.0006564244,0.001553688,0.002049592,0.001036369,0.00117933],"category_scores_gemma":[0.04955042,0.0002992603,0.0008779232,0.001116767,0.000576465,0.0009127602,0.00214453,0.0008704599,0.0005957054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009279125,"about_ca_system_score_gemma":0.002195824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001840747,"about_ca_topic_score_gemma":0.002722423,"domain_scores_codex":[0.9863165,0.006684614,0.001942318,0.001225255,0.00326701,0.0005643517],"domain_scores_gemma":[0.9609748,0.01825189,0.004146166,0.002458246,0.01239708,0.001771933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003793598,0.0001992352,0.9526539,0.0001834256,0.0001708893,0.0002332161,0.0001662528,0.001564345,0.002417011,0.0003479671,0.001341825,0.04034265],"study_design_scores_gemma":[0.0002547701,0.001205868,0.9103136,0.0005646953,0.0005692639,0.00456471,0.0007297058,0.06065358,0.010553,0.001330816,0.00916788,0.000092126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9571737,0.002971566,0.03071492,0.0008751026,0.0002571486,0.001258602,0.001802912,0.0001909487,0.004755034],"genre_scores_gemma":[0.9522886,0.0003337414,0.04364685,0.0001546523,0.0001019638,0.0004674199,0.002755276,0.00002108593,0.0002305484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01950625,"threshold_uncertainty_score":0.1031602,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388798703","doi":"10.1016/j.jtocrr.2023.100602","title":"Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Université du Québec à Trois-Rivières","funders":"Fonds de Recherche du Québec - Santé; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval","keywords":"Pembrolizumab; Nivolumab; Radiomics; Concordance; Medicine; Oncology; Internal medicine; Cohort; Imaging biomarker; Biomarker; Radiology; Immunotherapy; Cancer; Magnetic resonance imaging","authors":[{"name":"Sevinj Yolchuyeva","is_ca":true},{"name":"Elena Giacomazzi","is_ca":true},{"name":"Marion Tonneau","is_ca":true},{"name":"Fabien Lamaze","is_ca":false},{"name":"Michèle Orain","is_ca":false},{"name":"François Coulombe","is_ca":false},{"name":"Julie Malo","is_ca":true},{"name":"Wiam Belkaïd","is_ca":true},{"name":"Bertrand Routy","is_ca":true},{"name":"Philippe Joubert","is_ca":true},{"name":"Venkata Manem","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07396518050724483,"gpt":0.4467872464758412,"spread":0.3728220659685964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002544339,0.0005765758,0.0007166485,0.0007451277,0.0006470279,0.0007512384,0.0005451547,0.0005875561,0.0004777382],"category_scores_gemma":[0.002528273,0.0004043167,0.001118804,0.0007765035,0.000530768,0.0006703959,0.0008334309,0.000761266,0.0001517263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007554851,"about_ca_system_score_gemma":0.0005642343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002434458,"about_ca_topic_score_gemma":0.00271934,"domain_scores_codex":[0.9992628,0.0002704104,0.00007771332,0.0002097806,0.00009512468,0.00008418038],"domain_scores_gemma":[0.9980829,0.0003046523,0.0007062804,0.0003184172,0.0002749382,0.0003128388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009242572,0.0003172781,0.995876,0.00001070554,0.0002867516,0.00008182263,0.0001073311,0.0002092998,0.0005318467,0.000009903499,0.00007850485,0.001566322],"study_design_scores_gemma":[0.000115854,0.001081992,0.9946497,0.00000881701,0.0003515144,0.0004539026,0.0003081896,0.00231656,0.0003996082,0.00003841839,0.0002587405,0.00001676852],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996963,0.00005681015,0.0001009636,0.00001262898,0.000001873956,0.00001483377,0.00007030682,0.000002031177,0.00004432322],"genre_scores_gemma":[0.999508,0.00003482019,0.0001208351,0.00001737689,0.000007133299,0.00001901792,0.0002646355,0.000001352762,0.00002683584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002544339,"threshold_uncertainty_score":0.01345593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220684825","doi":"10.1016/j.jtocrr.2022.100316","title":"Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Toxicity; Internal medicine; Regimen; Cohort; Chemoradiotherapy; Log-rank test; Cisplatin; Proportional hazards model; Overall survival; Surgery; Chemotherapy; Cancer","authors":[{"name":"Marie-Hélène Denault","is_ca":false},{"name":"Shelley Kuang","is_ca":false},{"name":"Aria Shokoohi","is_ca":false},{"name":"Bonnie Leung","is_ca":false},{"name":"Mitchell Liu","is_ca":false},{"name":"Eric Berthelet","is_ca":false},{"name":"Janessa Laskin","is_ca":false},{"name":"Sophie Sun","is_ca":false},{"name":"Tina Zhang","is_ca":false},{"name":"Barbara Melosky","is_ca":false},{"name":"Cheryl Ho","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.145011355453734,"gpt":0.4879666751240869,"spread":0.3429553196703529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002821197,0.0003276461,0.001159798,0.0005224685,0.0001229758,0.0006295326,0.0003999807,0.000515771,0.001166795],"category_scores_gemma":[0.002415941,0.0001597475,0.001454879,0.000530681,0.000197321,0.0004239147,0.0001643035,0.0003723188,0.0001946085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008073782,"about_ca_system_score_gemma":0.0006907633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006013637,"about_ca_topic_score_gemma":0.001486044,"domain_scores_codex":[0.9989588,0.0005282979,0.0001852063,0.0001062638,0.0001409331,0.00008057706],"domain_scores_gemma":[0.9987189,0.0005589928,0.0004398249,0.00006308915,0.0001050616,0.0001142719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1365306,0.002528177,0.06829595,0.007079991,0.005428312,0.0007877956,0.0002075482,0.0008794771,0.0156083,0.0002505986,0.001383292,0.7610199],"study_design_scores_gemma":[0.03203566,0.4108213,0.4793456,0.003075427,0.02104653,0.007186786,0.0003840277,0.002939478,0.0113078,0.0003118725,0.03141787,0.0001276631],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7359781,0.2605276,0.0007390731,0.0005119822,0.0003870973,0.0004331515,0.0001855649,0.00002925921,0.001208098],"genre_scores_gemma":[0.9202679,0.07576197,0.001099484,0.0004978997,0.001143149,0.0002383521,0.0004537161,0.00001349871,0.0005240761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002821197,"threshold_uncertainty_score":0.01492006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386570892","doi":"10.1016/j.jtocrr.2023.100572","title":"Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"William Osler Health System; University of Toronto","funders":"Daiichi Sankyo Europe; National Cancer Institute; Chugai Pharmaceutical; Merck Sharp and Dohme; Genentech; Oryzon Genomics; BeiGene; Merck KGaA; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Placebo; Internal medicine; Lung cancer; Quality of life (healthcare); Hazard ratio; Confidence interval; Etoposide; Oncology; Chemotherapy; Surgery; Cancer; Pathology; Immunotherapy; Nursing","authors":[{"name":"Hye Ryun Kim","is_ca":false},{"name":"Mark M. Awad","is_ca":false},{"name":"Alejandro Navarro","is_ca":false},{"name":"Maya Gottfried","is_ca":false},{"name":"Solange Peters","is_ca":false},{"name":"Tibor Csőszi","is_ca":false},{"name":"Parneet Cheema","is_ca":true},{"name":"Delvys Rodríguez‐Abreu","is_ca":false},{"name":"Mirjana Wollner","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Julien Mazières","is_ca":false},{"name":"Francisco J. Orlandi","is_ca":false},{"name":"Alexander Luft","is_ca":false},{"name":"Mahmut Gümüş","is_ca":false},{"name":"Terufumi Kato","is_ca":false},{"name":"Gregory P. Kalemkerian","is_ca":false},{"name":"Yiwen Luo","is_ca":false},{"name":"Melissa L. Santorelli","is_ca":false},{"name":"M. Catherine Pietanza","is_ca":false},{"name":"Charles M. Rudin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3304689780494397,"gpt":0.5523388797000741,"spread":0.2218699016506344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001146523,0.0006566772,0.001750597,0.000242279,0.0001908536,0.0005884208,0.0005247323,0.0007405307,0.005279799],"category_scores_gemma":[0.0008730836,0.0003099887,0.0007867372,0.0002657789,0.0005190878,0.0005411676,0.0004036739,0.001390559,0.0004312394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004426001,"about_ca_system_score_gemma":0.0004980186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003394845,"about_ca_topic_score_gemma":0.0006326627,"domain_scores_codex":[0.9995512,0.0001984479,0.00005136884,0.0000855436,0.00005446496,0.00005895288],"domain_scores_gemma":[0.9996874,0.00006296229,0.0001131339,0.00001887637,0.00001588704,0.0001018511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8692164,0.01318064,0.003454318,0.001291882,0.0009797753,0.00006709158,0.00007551464,0.0009104497,0.03891489,0.00007972826,0.001293896,0.07053529],"study_design_scores_gemma":[0.4373004,0.5128333,0.03518197,0.0001348742,0.001399877,0.0002105897,0.00006185914,0.001222137,0.00943587,0.00015428,0.002028736,0.00003602256],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951527,0.002748753,0.000160764,0.0001381387,0.00008773994,0.0003766213,0.0004008941,0.00004368246,0.0008907275],"genre_scores_gemma":[0.9971883,0.0008434953,0.0003203475,0.000167352,0.00006612801,0.000501235,0.0003773785,0.00000487845,0.0005310604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005279799,"threshold_uncertainty_score":0.0176627,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4296202942","doi":"10.1016/j.jtocrr.2022.100408","title":"A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Medicine; Carboplatin; Tolerability; Pemetrexed; Rash; Internal medicine; Adverse effect; Neutropenia; Febrile neutropenia; Dosing; Loading dose; Oncology; Gastroenterology; Pharmacology; Urology; Toxicity; Chemotherapy; Cisplatin","authors":[{"name":"Sarina A. Piha‐Paul","is_ca":false},{"name":"George R. Simon","is_ca":false},{"name":"Chandra P. Belani","is_ca":false},{"name":"Heman Chao","is_ca":true},{"name":"Kim Gaspar","is_ca":true},{"name":"Brenda Lee","is_ca":true},{"name":"Afshin Dowlati","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2669794915815009,"gpt":0.5310140040131872,"spread":0.2640345124316864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000907114,0.001359674,0.002042465,0.0004586595,0.0003581511,0.0008510306,0.0008171459,0.0009858828,0.002383629],"category_scores_gemma":[0.000649329,0.0006383391,0.001126752,0.0003512857,0.0009470735,0.0008061512,0.0002956367,0.002529136,0.0005848241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008105448,"about_ca_system_score_gemma":0.001245966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007716395,"about_ca_topic_score_gemma":0.002179094,"domain_scores_codex":[0.9996878,0.0001313827,0.00001730237,0.00006915935,0.00003599754,0.00005836306],"domain_scores_gemma":[0.9995448,0.00007144186,0.0001204379,0.0000461412,0.0000318077,0.0001853114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.534964,0.1543253,0.008094112,0.001920233,0.002339969,0.0004040949,0.0009294914,0.005429683,0.1535902,0.0003215992,0.00346549,0.1342159],"study_design_scores_gemma":[0.2899557,0.6874359,0.01159534,0.00003830954,0.00041248,0.0002286674,0.00009334132,0.00126283,0.006776202,0.0001277968,0.002036483,0.00003701639],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965874,0.0009112269,0.0003102917,0.0001454116,0.00005676975,0.001021454,0.000287441,0.00005215201,0.0006278591],"genre_scores_gemma":[0.993674,0.001171209,0.001061729,0.0003450233,0.00008646024,0.001067872,0.0008625411,0.00002132723,0.001709755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002383629,"threshold_uncertainty_score":0.007974029,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282843614","doi":"10.1016/j.jtocrr.2022.100356","title":"Bilateral Pleural Mesothelioma In Situ and Peritoneal Mesothelioma In Situ Associated With BAP1 Germline Mutation: A Case Report","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of Alberta","funders":"","keywords":"BAP1; Mesothelioma; Germline; Peritoneal mesothelioma; Germline mutation; Medicine; Pleural cavity; Pathology; In situ; Cancer research; Mutation; Biology; Surgery; Genetics; Gene; Chemistry","authors":[{"name":"A. H. Maclean","is_ca":true},{"name":"Andrew Churg","is_ca":true},{"name":"Scott Thomas Johnson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06862817006105591,"gpt":0.4137199019763877,"spread":0.3450917319153318,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000523235,0.003072275,0.002010834,0.003683416,0.003215434,0.002629076,0.001777491,0.005846387,0.003038424],"category_scores_gemma":[0.003175,0.002707555,0.001477178,0.002121541,0.002491155,0.002622601,0.003297988,0.004148146,0.001206261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001080592,"about_ca_system_score_gemma":0.0007500377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001575183,"about_ca_topic_score_gemma":0.001980112,"domain_scores_codex":[0.9989734,0.00009378615,0.000116024,0.0003273633,0.0002089731,0.0002805141],"domain_scores_gemma":[0.9972989,0.0006386822,0.0005521335,0.0003088693,0.0001318187,0.001069655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00002115302,0.00003528993,0.003757019,0.00003363666,0.00001488487,0.994198,0.00010616,0.00004835814,0.0009898341,0.00009865944,0.0001047895,0.0005922921],"study_design_scores_gemma":[0.000008579581,0.00002735305,0.002071753,0.000005075807,0.00001068154,0.9972684,0.00004866554,0.0001060461,0.000202319,0.00006956545,0.000173851,0.000007745987],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804065,0.004555256,0.004358789,0.001903864,0.0003623291,0.0001963193,0.0003674391,0.0002983748,0.00755104],"genre_scores_gemma":[0.9953858,0.001088223,0.00150524,0.0003244302,0.0006611852,0.00002838895,0.00009461133,0.00002331286,0.0008887675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005846387,"threshold_uncertainty_score":0.01016456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3085200587","doi":"10.1016/j.jtocrr.2020.100097","title":"Two-Year Follow-Up of a Randomized Controlled Study of Integrated Smoking Cessation in a Lung Cancer Screening Program","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Alberta; Brock University; University of Calgary","funders":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","keywords":"Smoking cessation; Medicine; Lung cancer; Randomized controlled trial; Lung cancer screening; Cancer; Oncology; Environmental health; Internal medicine; Pathology","authors":[{"name":"Alain Tremblay","is_ca":true},{"name":"Niloofar Taghizadeh","is_ca":true},{"name":"Paul MacEachern","is_ca":true},{"name":"Paul Burrowes","is_ca":true},{"name":"Andrew J. Graham","is_ca":true},{"name":"Stephen Lam","is_ca":false},{"name":"Huiming Yang","is_ca":true},{"name":"Rommy Koetzler","is_ca":true},{"name":"Martin C. Tammemägi","is_ca":true},{"name":"Kathryn L. Taylor","is_ca":false},{"name":"Eric L.R. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1484564096100268,"gpt":0.4971038265500348,"spread":0.348647416940008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008746872,0.001644243,0.004683518,0.001355619,0.001357515,0.001307978,0.0009222628,0.002889187,0.008715807],"category_scores_gemma":[0.0122897,0.00125742,0.003420164,0.0009222096,0.00120961,0.001281782,0.001011176,0.002496255,0.0008654906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001375501,"about_ca_system_score_gemma":0.002733996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004622043,"about_ca_topic_score_gemma":0.003914803,"domain_scores_codex":[0.9932446,0.00365271,0.0006041664,0.0008723126,0.0005431535,0.001083076],"domain_scores_gemma":[0.9936899,0.001909828,0.001105678,0.0008222119,0.0008432933,0.00162904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9446182,0.03171534,0.005893776,0.0003566247,0.001644581,0.00004901217,0.00009288509,0.0002421406,0.000649011,0.00005689855,0.0005403149,0.01414131],"study_design_scores_gemma":[0.6992882,0.2501785,0.04575469,0.00008569654,0.002618013,0.00002836538,0.00005914226,0.0006010402,0.0005376213,0.0001132324,0.0006991291,0.00003640054],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866996,0.001572242,0.0004968906,0.0002419207,0.0003912147,0.008146487,0.0009817955,0.00007505947,0.00139489],"genre_scores_gemma":[0.9812961,0.0005531418,0.000881064,0.0004624335,0.000349868,0.01189971,0.001441917,0.00001132508,0.003104364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008746872,"threshold_uncertainty_score":0.04625845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389850548","doi":"10.1016/j.jtocrr.2023.100621","title":"Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Oncology; Adjuvant; Internal medicine; Subgroup analysis; Stage (stratigraphy); Epidermal growth factor receptor; Meta-analysis; Biology; Cancer; Erlotinib","authors":[{"name":"Jie Wang","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Shun Lü","is_ca":false},{"name":"Qun Wang","is_ca":false},{"name":"Shanqing Li","is_ca":false},{"name":"Wen‐Zhao Zhong","is_ca":false},{"name":"Qiming Wang","is_ca":false},{"name":"Wěi Li","is_ca":false},{"name":"Buhai Wang","is_ca":false},{"name":"Jun Chen","is_ca":false},{"name":"Ying Cheng","is_ca":false},{"name":"Hongbing Duan","is_ca":false},{"name":"Gaofeng Li","is_ca":false},{"name":"Shan Li","is_ca":false},{"name":"Yangbo Liu","is_ca":false},{"name":"Jing Liu","is_ca":false},{"name":"Xiangning Huang","is_ca":false},{"name":"Ana Bolanos","is_ca":true},{"name":"Jie He","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04608447736501201,"gpt":0.4356944729193147,"spread":0.3896099955543027,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002117203,0.001439382,0.002954444,0.001059704,0.0005123853,0.0009333423,0.0006429413,0.0007064171,0.001899181],"category_scores_gemma":[0.001031621,0.0004686929,0.006942628,0.001092168,0.0003300819,0.0003361508,0.0005789174,0.0006969373,0.0002319948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009799117,"about_ca_system_score_gemma":0.001788295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004490239,"about_ca_topic_score_gemma":0.01434745,"domain_scores_codex":[0.9988621,0.0003928173,0.0001449576,0.0002237713,0.0001704702,0.0002059096],"domain_scores_gemma":[0.9994751,0.00009002401,0.0001307737,0.0001165506,0.00007401982,0.0001135784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4170656,0.001553496,0.4245761,0.002489705,0.0832044,0.0009168014,0.000462161,0.002363608,0.01129074,0.0003578221,0.004697753,0.0510218],"study_design_scores_gemma":[0.1037654,0.02185687,0.7428524,0.0002987768,0.1131341,0.0005860458,0.0005897102,0.005092886,0.002258932,0.0007522258,0.008640246,0.0001724558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849867,0.01004669,0.0005065248,0.0002849667,0.0001256142,0.0007738038,0.001929038,0.00001844631,0.001328278],"genre_scores_gemma":[0.9941313,0.001129722,0.0002974328,0.0003573335,0.0001141668,0.0006463344,0.00221717,0.000009843888,0.001096692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004490239,"threshold_uncertainty_score":0.01119697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405556325","doi":"10.1016/j.jtocrr.2024.100781","title":"Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research","year":2024,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Chonnam National University; Princess Margaret Cancer Foundation","keywords":"Lung cancer; Oncology; Medicine; Cancer; Internal medicine","authors":[{"name":"Cheol‐Kyu Park","is_ca":true},{"name":"Maryam Khalil","is_ca":true},{"name":"Nhu‐An Pham","is_ca":true},{"name":"Stephanie M. Wong","is_ca":true},{"name":"Dalam Ly","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5703970070624337,"gpt":0.6704910618664188,"spread":0.1000940548039851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001509959,0.000869251,0.001378892,0.003114201,0.0002314623,0.001519566,0.001165718,0.001169743,0.002800544],"category_scores_gemma":[0.001044229,0.000380717,0.0006955555,0.002523476,0.0006889258,0.001824946,0.0006220855,0.00226538,0.002194879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006061126,"about_ca_system_score_gemma":0.001175074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007919684,"about_ca_topic_score_gemma":0.001298322,"domain_scores_codex":[0.9996597,0.00007975675,0.00005788107,0.00004742297,0.0001278397,0.00002743833],"domain_scores_gemma":[0.9992029,0.0004655886,0.0001046704,0.00002483472,0.0001516451,0.00005034513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001070137,0.0001553217,0.0002199679,0.02277122,0.00007905852,0.000245969,0.00007251318,0.0003319035,0.006996936,0.006461014,0.0287324,0.9338267],"study_design_scores_gemma":[0.0000161827,0.000169892,0.00054444,0.003911938,0.0001261681,0.001131317,0.00004906533,0.00006790602,0.001574956,0.001659803,0.9907237,0.00002470446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001164685,0.9982777,0.0003258087,0.0002254847,0.0001744622,0.00001315601,0.00003438189,0.00001185239,0.000820698],"genre_scores_gemma":[0.000352061,0.9985758,0.0004588878,0.000138446,0.00008636613,0.00001572021,0.00004289949,0.000002767303,0.0003270278],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003114201,"threshold_uncertainty_score":0.009368777,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049475230","doi":"10.1016/j.jtocrr.2020.100083","title":"Survival Outcomes of Salvage Therapy for Local and Regionally Recurrent NSCLC","year":2020,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Eisai; Boehringer Ingelheim; Roche","keywords":"Medicine; Radiation therapy; Cohort; Curative treatment; Stage (stratigraphy); Retrospective cohort study; Surgery; Population; Chemotherapy; Palliative care; Radiosurgery; Internal medicine; Disease","authors":[{"name":"Sara Moore","is_ca":true},{"name":"Bonnie Leung","is_ca":false},{"name":"Jonn Wu","is_ca":true},{"name":"Cheryl Ho","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2690976024827529,"gpt":0.5162934747583426,"spread":0.2471958722755898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006471003,0.0001430847,0.0003915512,0.000312727,0.0001913543,0.0004693689,0.0002230762,0.0002613836,0.001236089],"category_scores_gemma":[0.001600355,0.00005810091,0.0006872365,0.0002668626,0.0001897181,0.0003118021,0.0002901985,0.0002600483,0.0002056612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006383449,"about_ca_system_score_gemma":0.0002956227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032252,"about_ca_topic_score_gemma":0.00205628,"domain_scores_codex":[0.9997184,0.00006216817,0.00002933051,0.00006214096,0.00006490845,0.00006298809],"domain_scores_gemma":[0.998931,0.000144705,0.0006277019,0.00005729826,0.00006753614,0.0001718224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001352476,0.0001131155,0.9570522,0.00006518703,0.0003245022,0.0005819248,0.00009939664,0.0008789169,0.001802507,0.0000695982,0.0004342191,0.03722591],"study_design_scores_gemma":[0.00004376629,0.001847047,0.9931195,0.00003511774,0.0002185683,0.002034531,0.0001048298,0.000872182,0.000643905,0.0001606939,0.0009101029,0.000009825563],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971023,0.001796916,0.0001784511,0.00007543408,0.00001005886,0.000008310718,0.0003498878,0.00000789491,0.0004706605],"genre_scores_gemma":[0.9989061,0.0002963731,0.00005332195,0.00003022668,0.00001567357,0.000006421052,0.0005382132,0.000002028805,0.000151521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001236089,"threshold_uncertainty_score":0.004631579,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392453313","doi":"10.1016/j.jtocrr.2024.100660","title":"Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Helse Midt-Norge; Norges Teknisk-Naturvitenskapelige Universitet","keywords":"Task force; Lung cancer; Cohort; Selection (genetic algorithm); Medicine; Cancer; Cohort study; Lung cancer screening; Task (project management); Demography; Environmental health; Oncology; Family medicine; Internal medicine; Political science; Computer science; Economics; Public administration; Management; Sociology; Artificial intelligence","authors":[{"name":"Olav Toai Duc Nguyen","is_ca":false},{"name":"Ioannis Fotopoulos","is_ca":false},{"name":"Maria Markaki","is_ca":false},{"name":"Ioannis Tsamardinos","is_ca":false},{"name":"Vincenzo Lagani","is_ca":true},{"name":"Oluf Dimitri Røe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05097113252259333,"gpt":0.469072000425436,"spread":0.4181008679028426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03661385,0.0009371843,0.001425688,0.0008594049,0.0003690539,0.001304234,0.000999069,0.0007543654,0.0006756696],"category_scores_gemma":[0.04186251,0.0004469078,0.002418004,0.0005765966,0.000387528,0.000831609,0.0009462905,0.0008062023,0.0001381721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009235449,"about_ca_system_score_gemma":0.002103034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0311823,"about_ca_topic_score_gemma":0.02348059,"domain_scores_codex":[0.9896918,0.008511914,0.0003581941,0.0007295249,0.0004366381,0.0002719207],"domain_scores_gemma":[0.9741499,0.02042765,0.001886002,0.001694016,0.0011217,0.0007207643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004137491,0.0002231759,0.9671018,0.00006004973,0.001563487,0.00007431392,0.0001294372,0.01711316,0.0001554438,0.0001871876,0.0008124299,0.008442076],"study_design_scores_gemma":[0.0009330586,0.003239555,0.6154703,0.0001323988,0.003329101,0.0002828561,0.0003648982,0.3734055,0.0004245473,0.001233401,0.0010817,0.0001026762],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922735,0.001026664,0.005139713,0.000239531,0.00007911727,0.00009669458,0.0007785892,0.00003828726,0.000327896],"genre_scores_gemma":[0.9946684,0.0001365808,0.003962666,0.00006033479,0.00004022162,0.00004658588,0.0009418053,0.0000153743,0.0001280499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03661385,"threshold_uncertainty_score":0.1936349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385973055","doi":"10.1016/j.jtocrr.2023.100562","title":"Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Kingston Health Sciences Centre; William Osler Health System; Queen's University; Brampton Civic Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; EMD Serono; Genentech; Incyte; Canadian Cancer Society Research Institute; Helsinn; BeiGene; Merck KGaA; Princess Margaret Cancer Foundation; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Oncology; Toxicity; Targeted therapy; Cancer","authors":[{"name":"Sally C.M. Lau","is_ca":true},{"name":"Kirstin Perdrizet","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Danilo Giffoni M. M. Mata","is_ca":true},{"name":"Jessica Weiss","is_ca":true},{"name":"Nick Holzapfel","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Harriet Feilotter","is_ca":true},{"name":"Brandon S. Sheffield","is_ca":true},{"name":"David Hwang","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Susanna Y. Cheng","is_ca":true},{"name":"Parneet Cheema","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09678955994710657,"gpt":0.459144782226494,"spread":0.3623552222793874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108723,0.0001866917,0.0006644565,0.0003649813,0.000167537,0.0003783944,0.0002975781,0.0002264346,0.0005462921],"category_scores_gemma":[0.0007607,0.00007599688,0.0004418159,0.0003466252,0.0003041194,0.0002885209,0.0001805797,0.000384191,0.00005852749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001780521,"about_ca_system_score_gemma":0.001649882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006185135,"about_ca_topic_score_gemma":0.02024793,"domain_scores_codex":[0.9996933,0.00008650286,0.00002894091,0.00004444945,0.0001067289,0.00004009542],"domain_scores_gemma":[0.9995311,0.0001470402,0.0001417933,0.00002786025,0.00006966188,0.00008252799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02472104,0.00124219,0.1221162,0.00103191,0.0007226661,0.0007237817,0.0002672282,0.005374013,0.04040369,0.0006416771,0.001203994,0.8015516],"study_design_scores_gemma":[0.004504909,0.1001759,0.816206,0.0005497845,0.002077411,0.007600819,0.0004613664,0.01263582,0.0359218,0.001463686,0.01832175,0.00008070492],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9578881,0.03846658,0.0008963882,0.0002923147,0.00002347669,0.0001166065,0.0001555419,0.00002127104,0.002139667],"genre_scores_gemma":[0.9930632,0.005433156,0.0008270936,0.00009220804,0.00002139083,0.00003851597,0.0001216768,0.000003396273,0.0003993938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006185135,"threshold_uncertainty_score":0.01291865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281720443","doi":"10.1016/j.jtocrr.2022.100350","title":"Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Impact; Alberta Health Services; University of Alberta; University of Calgary; Alberta Health","funders":"","keywords":"Medicine; Medical prescription; Lung cancer screening; Stage (stratigraphy); Lung cancer; Computed tomography; Health care; Cost–benefit analysis; Emergency medicine; Intensive care medicine; Radiology; Internal medicine","authors":[{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Truong‐Minh Pham","is_ca":true},{"name":"Arianna Waye","is_ca":true},{"name":"Alain Tremblay","is_ca":true},{"name":"Huiming Yang","is_ca":true},{"name":"Michelle L. Dean","is_ca":true},{"name":"Tracy Wasylak","is_ca":true},{"name":"Randeep Sangha","is_ca":true},{"name":"Douglas A. Stewart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06801608925398014,"gpt":0.4345918053243477,"spread":0.3665757160703675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001066378,0.0004813092,0.0002921394,0.001013985,0.000664101,0.001526248,0.001092881,0.0005693278,0.003362237],"category_scores_gemma":[0.003112634,0.0002470503,0.0007211709,0.001611337,0.0004263103,0.0003119111,0.0004742802,0.000561582,0.0002067047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05351052,"about_ca_system_score_gemma":0.04405567,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9746177,"about_ca_topic_score_gemma":0.9719902,"domain_scores_codex":[0.9988564,0.0002703592,0.00004262176,0.00006993326,0.0003413242,0.000419302],"domain_scores_gemma":[0.9986174,0.0003531951,0.0001670675,0.0000219504,0.0005336215,0.000306724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001474929,0.0003328596,0.6060585,0.000422016,0.0005879003,0.001105023,0.0002466333,0.3150859,0.001612223,0.01024176,0.01145549,0.0513768],"study_design_scores_gemma":[0.000618276,0.0007392769,0.5293491,0.0003357054,0.0008495447,0.0008747668,0.001594599,0.4446926,0.001547017,0.004872527,0.01439294,0.0001336276],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563052,0.002061604,0.003555245,0.005112627,0.00007856185,0.0002777853,0.01260408,0.0001371379,0.01986778],"genre_scores_gemma":[0.9919008,0.0007154275,0.00155597,0.0002493837,0.00001283056,0.00002514218,0.002244456,0.000007361938,0.003288582],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05351052,"threshold_uncertainty_score":0.3882478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403411452","doi":"10.1016/j.jtocrr.2024.100737","title":"CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; Centre Technologique des Résidus Industriels; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Lung cancer; Medicine; Cancer; Immunotherapy; Cancer research; Lung; Oncology; Internal medicine","authors":[{"name":"Antoine Desîlets","is_ca":true},{"name":"Wiam Belkaïd","is_ca":true},{"name":"Olivier Salko","is_ca":true},{"name":"Julie Malo","is_ca":true},{"name":"Eleyine Zarour","is_ca":true},{"name":"Adéline Jouquan","is_ca":true},{"name":"A. A. Thibaudeau","is_ca":true},{"name":"Marc‐Antoine Nolin","is_ca":true},{"name":"J. C. A. Stagg","is_ca":true},{"name":"Marie Florescu","is_ca":true},{"name":"Mustapha Tehfé","is_ca":true},{"name":"Normand Blais","is_ca":true},{"name":"Samer Tabchi","is_ca":true},{"name":"Jean Chalaoui","is_ca":true},{"name":"Philippe Stephenson","is_ca":true},{"name":"Arielle Elkrief","is_ca":true},{"name":"Vincent Quoc‐Huy Trinh","is_ca":true},{"name":"Bertrand Routy","is_ca":true},{"name":"Moïshe Liberman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09651927422717367,"gpt":0.4826450913431923,"spread":0.3861258171160186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001927468,0.001082738,0.002382194,0.0005682993,0.00054152,0.000882392,0.001051621,0.001106934,0.002825011],"category_scores_gemma":[0.0006885107,0.0004865804,0.001413031,0.0003673405,0.001158253,0.0008944993,0.0005102105,0.002201018,0.0005705761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006146588,"about_ca_system_score_gemma":0.001480837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008560148,"about_ca_topic_score_gemma":0.001657901,"domain_scores_codex":[0.9993535,0.0003279689,0.00002736591,0.0000961175,0.00004563876,0.000149366],"domain_scores_gemma":[0.9992773,0.0001591577,0.0000866855,0.00007172731,0.00005427413,0.0003507741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5561837,0.2431573,0.004955438,0.0009534991,0.001374956,0.000449362,0.0004577361,0.002568543,0.1065074,0.0002662349,0.001241138,0.08188473],"study_design_scores_gemma":[0.09686292,0.8946421,0.003555656,0.00001649443,0.0002449682,0.000110636,0.00004516171,0.0004856207,0.003265023,0.00005988366,0.0006975992,0.00001408977],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960744,0.001184852,0.0003337196,0.0001618837,0.00008977917,0.00146156,0.0001549621,0.00003311439,0.0005057122],"genre_scores_gemma":[0.9946749,0.001162524,0.0007519134,0.0002117002,0.0001588273,0.001729852,0.0002958021,0.00001145085,0.001003022],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002825011,"threshold_uncertainty_score":0.01019353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200545467","doi":"10.1016/j.jtocrr.2021.100259","title":"Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Ethnic group; Confidence interval; Oncology; Subgroup analysis","authors":[{"name":"Pascale Tomasini","is_ca":true},{"name":"Lisa W. Le","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Ming‐Sound Tsao","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Janice J.N. Li","is_ca":true},{"name":"Ronald Feld","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03152248506292136,"gpt":0.4202601434878151,"spread":0.3887376584248937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009495043,0.0001892114,0.0003139461,0.0003719809,0.0003628684,0.0006913593,0.0003094713,0.0003020606,0.002215113],"category_scores_gemma":[0.003527384,0.0001144465,0.0008236074,0.0004202911,0.000330283,0.000590402,0.0006106197,0.0006148451,0.0001963159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004583173,"about_ca_system_score_gemma":0.000389135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002024469,"about_ca_topic_score_gemma":0.004517761,"domain_scores_codex":[0.9993179,0.0002189267,0.0000846497,0.0001148018,0.0001092734,0.0001544915],"domain_scores_gemma":[0.997206,0.0005654288,0.001378752,0.0001015573,0.0001797247,0.0005685433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005778099,0.00002993626,0.9974996,0.00001051802,0.0001183471,0.00008226212,0.00003212819,0.00006472728,0.0001068168,0.00001953116,0.00006031187,0.001397994],"study_design_scores_gemma":[0.00001106986,0.0001939338,0.9989108,0.00001213761,0.00006334154,0.0001924507,0.0002029767,0.0001718722,0.00005628445,0.0000459358,0.0001344179,0.000004719548],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985462,0.000524696,0.00004015609,0.0001041048,0.00001675694,0.000003846609,0.0001741869,0.000001468157,0.0005885436],"genre_scores_gemma":[0.9995166,0.0001172429,0.00001559556,0.00003212396,0.00001580973,0.000003256914,0.0001987611,0.000001163503,0.00009931398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002215113,"threshold_uncertainty_score":0.007410288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388666126","doi":"10.1016/j.jtocrr.2023.100601","title":"Real-World Immunotherapy Use and Effectiveness in Advanced NSCLC With Programmed Death-Ligand 1 Greater Than or Equal to 50% and Greater Than or Equal to 90%","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Internal medicine; Cohort; Oncology; PD-L1; Immunotherapy; Clinical endpoint; Chemotherapy; Population; Cancer; Clinical trial","authors":[{"name":"Ashley Jackson","is_ca":true},{"name":"Nina Chang","is_ca":true},{"name":"Deborah Akurang","is_ca":true},{"name":"Paul Wheatley‐Price","is_ca":true},{"name":"Sara Moore","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.204960016965594,"gpt":0.4796957161427269,"spread":0.2747356991771329,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001857962,0.0001047787,0.0002122085,0.001177035,0.0002284145,0.0006432413,0.0003403844,0.0003874361,0.0009807224],"category_scores_gemma":[0.005780926,0.000119437,0.0002674351,0.001124586,0.0003411052,0.0007909265,0.0003570833,0.0002970675,0.0001929668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008248377,"about_ca_system_score_gemma":0.0003889615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001346068,"about_ca_topic_score_gemma":0.003052872,"domain_scores_codex":[0.9986081,0.0005686308,0.0002941377,0.0001836314,0.0002241735,0.0001213879],"domain_scores_gemma":[0.9926769,0.001816808,0.004587377,0.0001250643,0.0002926364,0.0005011233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002055406,0.0000329467,0.9967725,0.00002765876,0.00003509302,0.00007359916,0.00003712183,0.0001096605,0.00007724255,0.00002196646,0.00007674105,0.002529995],"study_design_scores_gemma":[0.00001708591,0.0002403428,0.9977769,0.00001758958,0.00002844637,0.0006909608,0.0001362461,0.0004643202,0.0001363963,0.0000552848,0.00042894,0.000007502154],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972878,0.001301201,0.00008969123,0.0001319388,0.000005656213,0.00001126221,0.0006777508,0.000002985596,0.0004917237],"genre_scores_gemma":[0.9988837,0.0003664367,0.0001370235,0.00003710922,0.00001702109,0.00001316012,0.0004936942,0.000001098767,0.00005075974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001857962,"threshold_uncertainty_score":0.009826005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404630193","doi":"10.1016/j.jtocrr.2024.100772","title":"Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors","year":2024,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Medicine; Immunology","authors":[{"name":"Abdulrahman Alghabban","is_ca":true},{"name":"Lucy Corke","is_ca":true},{"name":"Hans Katzberg","is_ca":true},{"name":"Vera Bril","is_ca":true},{"name":"Carolina Barnett‐Tapia","is_ca":true},{"name":"Warren Mason","is_ca":true},{"name":"Raed Alothman","is_ca":true},{"name":"David W. Hogg","is_ca":true},{"name":"Srikala S. Sridhar","is_ca":true},{"name":"Neesha C. Dhani","is_ca":true},{"name":"Anna Spreafico","is_ca":true},{"name":"Lawson Eng","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Penelope A. Bradbury","is_ca":true},{"name":"Geoffrey Liu","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1319917010569843,"gpt":0.4742182047809884,"spread":0.3422265037240041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003248524,0.0002257792,0.00035814,0.0004231842,0.0006776694,0.0005006796,0.0001916366,0.0005027973,0.001883063],"category_scores_gemma":[0.001837663,0.0001604294,0.0003029549,0.0005951112,0.0003505936,0.0003748103,0.0003522952,0.0005710195,0.0002301676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003400217,"about_ca_system_score_gemma":0.0004623087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069718,"about_ca_topic_score_gemma":0.001366862,"domain_scores_codex":[0.999715,0.00006623194,0.00003512021,0.00004887681,0.00005357869,0.00008110419],"domain_scores_gemma":[0.9989524,0.0002362438,0.0005257884,0.00002572317,0.00005066892,0.0002092176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009889535,0.00004358391,0.9868302,0.00002799185,0.00001622071,0.008958858,0.00009781331,0.00004957008,0.0003683067,0.00002563552,0.0002425353,0.003240454],"study_design_scores_gemma":[0.00004695785,0.0006408598,0.9304886,0.00006429123,0.00004771389,0.06676083,0.0003708852,0.0002195069,0.0002049961,0.00008448939,0.001062376,0.000008380115],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.995282,0.002030903,0.0001094173,0.0002891982,0.00002311474,0.0000429865,0.0001173431,0.00001268395,0.002092358],"genre_scores_gemma":[0.9990671,0.0004133706,0.0000949205,0.0001505805,0.00005580988,0.00001288916,0.00009771715,0.000001804033,0.0001057359],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001883063,"threshold_uncertainty_score":0.006299436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391919142","doi":"10.1016/j.jtocrr.2024.100647","title":"Cabozantinib Response in a Patient With NSCLC Harboring Both MET Exon 14 Skipping Mutation and Secondary RET Fusion: A Case Report","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cabozantinib; Medicine; Exon; Exon skipping; Mutation; Cancer research; Oncology; Targeted therapy; Internal medicine; Cancer; Genetics; Gene; Biology","authors":[{"name":"Jamie Feng","is_ca":true},{"name":"Elizabeth Faour","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06866051547325637,"gpt":0.4670181337328081,"spread":0.3983576182595517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004144609,0.00163282,0.001878177,0.002592271,0.002496464,0.002437055,0.00128135,0.007488501,0.00253741],"category_scores_gemma":[0.002018069,0.001292031,0.002115232,0.001147753,0.001539827,0.002047413,0.00138313,0.005235302,0.001106137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002099597,"about_ca_system_score_gemma":0.001247743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003852804,"about_ca_topic_score_gemma":0.006105228,"domain_scores_codex":[0.9991972,0.0000752545,0.00009725709,0.000214437,0.0001349113,0.0002808406],"domain_scores_gemma":[0.9982436,0.0004034916,0.0003113532,0.0001185,0.0001288267,0.0007942301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00003903346,0.00002592456,0.001729276,0.00001246144,0.000007774485,0.9968601,0.00005423928,0.00003600677,0.0004810674,0.00005543796,0.0001504879,0.000548054],"study_design_scores_gemma":[0.00001293812,0.00006989886,0.001502304,0.000006042102,0.00001968824,0.9971976,0.00005360201,0.0002540083,0.000472511,0.00005731373,0.0003456801,0.000008416923],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9638234,0.006582703,0.003606183,0.009288509,0.0005913217,0.0002553133,0.0005293783,0.0004161882,0.01490687],"genre_scores_gemma":[0.9907345,0.001781935,0.001718589,0.001953545,0.001064378,0.00002548817,0.0001937052,0.00005201401,0.002475826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007488501,"threshold_uncertainty_score":0.01523376,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391792531","doi":"10.1016/j.jtocrr.2024.100645","title":"Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; National Institutes of Health; Array BioPharma; Massachusetts General Hospital; Lunit; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Alectinib; Medicine; Oncology; Crizotinib; Internal medicine; Lung cancer","authors":[{"name":"Justin M. Cheung","is_ca":false},{"name":"Jiyoon Kang","is_ca":true},{"name":"Beow Y. Yeap","is_ca":true},{"name":"Jennifer Peterson","is_ca":false},{"name":"Andrew Do","is_ca":true},{"name":"Justin F. Gainor","is_ca":false},{"name":"Subba R. Digumarthy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03893543307576351,"gpt":0.4216651979989756,"spread":0.382729764923212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072212,0.0003502985,0.0008124522,0.0001830511,0.0001747652,0.0004725086,0.0003367669,0.0003143369,0.0004193508],"category_scores_gemma":[0.001483725,0.0001401025,0.0007057643,0.0002866851,0.0002514048,0.0002943888,0.0002388093,0.0008264821,0.0001491016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006939919,"about_ca_system_score_gemma":0.0005587456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004877172,"about_ca_topic_score_gemma":0.001016714,"domain_scores_codex":[0.9996471,0.0001160874,0.0000433357,0.00007089856,0.00007336325,0.00004908369],"domain_scores_gemma":[0.9993123,0.0001471492,0.0002659039,0.00006182436,0.00004545766,0.0001673456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1946189,0.006998843,0.5039476,0.000538677,0.002812039,0.001540098,0.0005500433,0.008217649,0.04719354,0.0001613718,0.001786262,0.231635],"study_design_scores_gemma":[0.02232321,0.1272421,0.8276775,0.0001024886,0.001405672,0.003653037,0.0001618884,0.007418467,0.007293776,0.0002019248,0.002466318,0.00005358911],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991056,0.0005245803,0.00005925915,0.00004930366,0.000004750446,0.00002416696,0.0000576161,0.000005723321,0.0001690633],"genre_scores_gemma":[0.999488,0.0001534112,0.00008605694,0.00004442617,0.000009467053,0.00001650657,0.0001480244,0.000001114366,0.00005298893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001072212,"threshold_uncertainty_score":0.005670488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377982006","doi":"10.1016/j.jtocrr.2023.100530","title":"Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Québec Science (Canada); McGill University Health Centre","funders":"","keywords":"ROS1; Immunohistochemistry; Adenocarcinoma; Lung cancer; Carcinogenesis; Cancer research; Fluorescence in situ hybridization; Medicine; Biology; Internal medicine; Pathology; Cancer; Oncology; Gene; Genetics","authors":[{"name":"Karl Grenier","is_ca":true},{"name":"Jean‐Baptiste Rivière","is_ca":true},{"name":"Bouchra Ouled Amar Bencheikh","is_ca":true},{"name":"Andrea Liliam Gomez Corredor","is_ca":true},{"name":"B. Shieh","is_ca":true},{"name":"Hangjun Wang","is_ca":true},{"name":"Pierre Fiset","is_ca":true},{"name":"Sophie Camilleri‐Broët","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04095527057484923,"gpt":0.4228655320139387,"spread":0.3819102614390895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007268175,0.0002222413,0.0002215138,0.0008298992,0.0002337916,0.0004314326,0.000272775,0.0003684709,0.001874212],"category_scores_gemma":[0.002601935,0.0002128894,0.000135791,0.0004598362,0.0005904661,0.0002796817,0.0002392218,0.0002677617,0.0002492344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002046275,"about_ca_system_score_gemma":0.0001665951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000447524,"about_ca_topic_score_gemma":0.0007135277,"domain_scores_codex":[0.9994279,0.0001536043,0.00007524819,0.00009997403,0.0001578014,0.00008551428],"domain_scores_gemma":[0.9984379,0.0005721957,0.0006101294,0.00009565241,0.0001269205,0.0001571749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002051304,0.00001963881,0.9816598,0.00002250746,0.00002159347,0.001035788,0.00004763003,0.0000538368,0.01412168,0.00003375791,0.00004842117,0.002730198],"study_design_scores_gemma":[0.000006777449,0.0001633644,0.9833246,0.000008439934,0.00004039537,0.00943107,0.0001708479,0.0003737442,0.006025839,0.0001177094,0.0003323744,0.000004938987],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981714,0.000671974,0.0003419397,0.00003261721,0.000004794073,0.000008729113,0.00004877017,0.000009133996,0.0007106678],"genre_scores_gemma":[0.9996443,0.00008984009,0.0001367639,0.000009018426,0.000006260504,0.000003487181,0.00003974346,0.000001357326,0.00006919666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001874212,"threshold_uncertainty_score":0.006269872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283463957","doi":"10.1016/j.jtocrr.2022.100371","title":"Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbotsford Veterinary Clinic; Positive Living North; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Oncology; Palliative care; Lung cancer; Cohort","authors":[{"name":"Daegan Sit","is_ca":true},{"name":"Michelle Bale","is_ca":true},{"name":"Vincent Lapointe","is_ca":true},{"name":"Robert Olson","is_ca":true},{"name":"Fred Hsu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07884287066603579,"gpt":0.4311160863668188,"spread":0.352273215700783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004509728,0.0000863434,0.000175399,0.0002807902,0.0001667621,0.0002644228,0.0002052627,0.0002271161,0.001358756],"category_scores_gemma":[0.001881349,0.00007670004,0.0002518804,0.0003919114,0.0001526802,0.0001618796,0.000184587,0.0002686777,0.00008067408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002962863,"about_ca_system_score_gemma":0.0002391035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004861547,"about_ca_topic_score_gemma":0.01182901,"domain_scores_codex":[0.9996089,0.0001107376,0.00005067007,0.00006199081,0.00009766503,0.00007002834],"domain_scores_gemma":[0.9987788,0.000306413,0.0006528093,0.00003467649,0.00009827801,0.0001291436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008212409,0.00001105061,0.9986724,0.000006613545,0.00002211261,0.00002472382,0.00001359459,0.00004722989,0.0001277796,0.000002636636,0.00003632292,0.0009534819],"study_design_scores_gemma":[0.000002987083,0.00003839928,0.9996711,0.000002426495,0.000007467667,0.00009538745,0.00002761047,0.00007924347,0.00002535715,0.000003376033,0.00004557897,9.926284e-7],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994247,0.0002042366,0.00002498611,0.00002596411,0.000001888658,0.000003765797,0.0001596317,0.000001009198,0.000153777],"genre_scores_gemma":[0.9997242,0.00005411448,0.00001815953,0.000007972209,0.000002984923,0.000003237571,0.0001470374,4.020277e-7,0.0000418264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004861547,"threshold_uncertainty_score":0.009666502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3181684306","doi":"10.1016/j.jtocrr.2021.100212","title":"A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University; Kingston Health Sciences Centre; London Health Sciences Centre; University of Calgary; University Health Network; Ottawa Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; Hamilton Regional Laboratory Medicine Program; Queen Elizabeth II Health Sciences Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Trillium Health Centre; AstraZeneca (Canada); McMaster University; Dalhousie University; Hamilton Health Sciences; Western University; University of Toronto","funders":"Roche; AstraZeneca Canada; AstraZeneca; Pfizer","keywords":"T790M; Concordance; Digital polymerase chain reaction; Mutation; Medicine; Resistance mutation; Polymerase chain reaction; Oncology; Internal medicine; Biology; Genetics; Gene; KRAS; Reverse transcriptase","authors":[{"name":"Shamini Selvarajah","is_ca":true},{"name":"Sophie Plante","is_ca":true},{"name":"Marsha Speevak","is_ca":true},{"name":"Andrea K. Vaags","is_ca":true},{"name":"Darren Hamelinck","is_ca":true},{"name":"Martin Butcher","is_ca":true},{"name":"M. Elizabeth McCready","is_ca":true},{"name":"Daria Grafodatskaya","is_ca":true},{"name":"Normand Blais","is_ca":true},{"name":"Danh Tran‐Thanh","is_ca":true},{"name":"Xiaoduan Weng","is_ca":true},{"name":"Rami Nassabein","is_ca":true},{"name":"Wenda Greer","is_ca":true},{"name":"Ryan N. Walton","is_ca":true},{"name":"Bernard Lo","is_ca":true},{"name":"Doug Demetrick","is_ca":true},{"name":"Stephanie Santos","is_ca":true},{"name":"Bekim Sadiković","is_ca":true},{"name":"Xiao Zhang","is_ca":true},{"name":"Tong Zhang","is_ca":true},{"name":"Tara Spence","is_ca":true},{"name":"Tracy Stockley","is_ca":true},{"name":"Harriet Feilotter","is_ca":true},{"name":"Philippe Joubert","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708741524963086,"gpt":0.5011210858427947,"spread":0.330246933346486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01090544,0.001080879,0.0004880569,0.001352087,0.003011844,0.001337309,0.00171172,0.0009908925,0.0020717],"category_scores_gemma":[0.01517176,0.0006006368,0.0008054475,0.002183739,0.00126329,0.0005649159,0.001182953,0.001027519,0.000597803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01526574,"about_ca_system_score_gemma":0.02343935,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8967743,"about_ca_topic_score_gemma":0.9038479,"domain_scores_codex":[0.993709,0.001308846,0.0003580376,0.00131193,0.002725625,0.0005866252],"domain_scores_gemma":[0.9814157,0.001656532,0.001578653,0.001308804,0.01245759,0.001582633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002209281,0.0005748796,0.9623994,0.0002707737,0.0006049846,0.0001946927,0.001456914,0.0005177479,0.005846082,0.0006238904,0.006116711,0.0191847],"study_design_scores_gemma":[0.0002422433,0.0005443098,0.9894543,0.00006073,0.0002609018,0.0004122782,0.0004546354,0.001072205,0.001558036,0.00005363621,0.005849834,0.00003700516],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786723,0.001275014,0.003497187,0.0007998337,0.00009075854,0.001074968,0.007772683,0.0001267213,0.006690447],"genre_scores_gemma":[0.988301,0.0003942375,0.003958275,0.000637205,0.00003156342,0.0003049361,0.00492605,0.00007004667,0.001376685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1032257,"threshold_uncertainty_score":0.2076672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393204492","doi":"10.1016/j.jtocrr.2024.100669","title":"Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi Genzyme; AstraZeneca Korea; EMD Serono; Genentech; Daiichi-Sankyo; G1 Therapeutics; BeiGene; Mirati Therapeutics; AstraZeneca; Novocure; Regeneron Pharmaceuticals; Sanofi; Amgen; American Association for Cancer Research; Eli Lilly and Company; Bristol-Myers Squibb; Seagen; LUNGevity Foundation; Pfizer","keywords":"Osimertinib; Oncology; Medicine; Retrospective cohort study; Cohort; Internal medicine; Mutant; Term (time); Cancer; Epidermal growth factor receptor; Biology; Genetics; Gene; Erlotinib","authors":[{"name":"William Tompkins","is_ca":false},{"name":"Connor B. Grady","is_ca":false},{"name":"Wei‐Ting Hwang","is_ca":false},{"name":"Krishna Chandrasekhara","is_ca":false},{"name":"Caroline E. McCoach","is_ca":false},{"name":"Fangdi Sun","is_ca":false},{"name":"Geoffrey Liu","is_ca":true},{"name":"Devalben Patel","is_ca":true},{"name":"Jorgé Nieva","is_ca":false},{"name":"Amanda Herrmann","is_ca":false},{"name":"Kristen A. Marrone","is_ca":false},{"name":"Vincent K. Lam","is_ca":false},{"name":"Vamsi Velcheti","is_ca":false},{"name":"Stephen V. Liu","is_ca":false},{"name":"Gabriela Liliana Bravo Montenegro","is_ca":false},{"name":"Tejas Patil","is_ca":false},{"name":"Jared Weiss","is_ca":false},{"name":"Kelsey Leigh Miller","is_ca":false},{"name":"William Schwartzman","is_ca":false},{"name":"Jonathan E. Dowell","is_ca":false},{"name":"Khvaramze Shaverdashvili","is_ca":false},{"name":"Liza C. Villaruz","is_ca":false},{"name":"Amanda Cass","is_ca":false},{"name":"Wade T. Iams","is_ca":false},{"name":"Dara L. Aisner","is_ca":false},{"name":"Charu Aggarwal","is_ca":false},{"name":"D. Ross Camidge","is_ca":false},{"name":"Melina E. Marmarelis","is_ca":false},{"name":"Lova Sun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1094563096629582,"gpt":0.5031910424772752,"spread":0.3937347328143169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002833204,0.00009779025,0.0001871141,0.0004150168,0.0002479607,0.0003414752,0.0001755436,0.0002117727,0.001330631],"category_scores_gemma":[0.001046894,0.00006773975,0.0002166264,0.0005783227,0.0001683629,0.0003513729,0.0002425606,0.0001957682,0.0001262103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001964604,"about_ca_system_score_gemma":0.0002569572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002025513,"about_ca_topic_score_gemma":0.003137456,"domain_scores_codex":[0.9998487,0.00002112967,0.00002575067,0.00003493215,0.00002960972,0.00003986924],"domain_scores_gemma":[0.9989364,0.0001224272,0.0005824596,0.0000351616,0.00007882531,0.0002447584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002097048,0.000005155993,0.999315,0.000003144326,0.000008404443,0.00005788866,0.00001487105,0.00002144022,0.00006836568,0.000005407497,0.00003320666,0.0004461943],"study_design_scores_gemma":[0.000001099792,0.00006298395,0.9992018,0.000004420885,0.000007160007,0.0004187569,0.00009814811,0.00005163747,0.00003067132,0.00001250946,0.0001089758,0.000001832313],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991722,0.0001609028,0.00003551314,0.00002245057,0.000002135555,0.000003357079,0.0004166939,0.000002104625,0.0001846315],"genre_scores_gemma":[0.9994055,0.00006302858,0.00001980487,0.00001158113,0.000004794191,0.000003994435,0.0004284182,4.528906e-7,0.00006247013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002025513,"threshold_uncertainty_score":0.004451454,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387783616","doi":"10.1016/j.jtocrr.2023.100594","title":"Health Care Utilization and Costs in Lung Cancer Screening Participants—A Propensity-Matched Economic Analysis","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Alberta Health; Simon Fraser University; University of Alberta; University of Saskatchewan; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Lung cancer; Cohort; Confidence interval; Propensity score matching; Cohort study; Health care; Cancer; Demography; Emergency medicine; Internal medicine","authors":[{"name":"Alain Tremblay","is_ca":true},{"name":"Shainur Premji","is_ca":false},{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Huiming Yang","is_ca":true},{"name":"Paul MacEachern","is_ca":true},{"name":"Erika Penz","is_ca":true},{"name":"Sonya Cressman","is_ca":true},{"name":"Eric L.R. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3476252898537681,"gpt":0.4919756895256912,"spread":0.1443503996719231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005902247,0.0006446,0.001191213,0.002674556,0.0008144804,0.001199783,0.001165491,0.0008742144,0.002277957],"category_scores_gemma":[0.009273593,0.0006317132,0.004237678,0.002150791,0.0006256591,0.0005226082,0.001146637,0.0007522147,0.0001699461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002377761,"about_ca_system_score_gemma":0.001622362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03603255,"about_ca_topic_score_gemma":0.02051085,"domain_scores_codex":[0.9968675,0.001538808,0.0002396483,0.0004061302,0.0005952962,0.0003526649],"domain_scores_gemma":[0.9970493,0.000968178,0.0009885718,0.0004220317,0.0002771835,0.0002946877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006391154,0.000437398,0.9764028,0.00009033064,0.006808352,0.0002026364,0.00007703985,0.003355907,0.0002082551,0.0003438405,0.0004206813,0.005261569],"study_design_scores_gemma":[0.0009660208,0.001487972,0.9599835,0.00005641912,0.004200595,0.0003583317,0.0002461073,0.03076132,0.0001596872,0.0007349215,0.0009910277,0.00005390074],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997111,0.0004293609,0.001048918,0.00009572683,0.000010699,0.0001560948,0.0008850938,0.000006585658,0.0002565095],"genre_scores_gemma":[0.9980347,0.0001182656,0.0004478596,0.00002994654,0.00000993779,0.00007301818,0.001138454,0.000002088962,0.0001457693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03603255,"threshold_uncertainty_score":0.07164568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200254289","doi":"10.1016/j.jtocrr.2021.100269","title":"Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Foundation Medicine; Genentech; Merck Sharp and Dohme; Eli Lilly and Company; Ono Pharmaceutical; Daiichi-Sankyo; BeiGene; TG Therapeutics; Regeneron Pharmaceuticals; Johnson and Johnson; Takeda Pharmaceutical Company; Amgen; Boehringer Ingelheim; Chugai Pharmaceutical; Roche; Novartis; Sanofi; Merck; Pfizer; G1 Therapeutics; Daiichi Sankyo Europe; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Lung cancer; Medicine; Clinical trial; Cancer; Disease; Pandemic; Internal medicine; Oncology; Intensive care medicine; Family medicine; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","authors":[{"name":"Upal Roy","is_ca":false},{"name":"Anne‐Marie Baird","is_ca":false},{"name":"A. Ciupek","is_ca":false},{"name":"J. Fox","is_ca":false},{"name":"Eugene Manley","is_ca":false},{"name":"Kim Norris","is_ca":false},{"name":"Giorgio V. Scagliotti","is_ca":false},{"name":"Heather A. Wakelee","is_ca":false},{"name":"Tetsuya Mitsudomi","is_ca":false},{"name":"Russell Clark","is_ca":false},{"name":"Renee Arndt","is_ca":false},{"name":"Fred R. Hirsch","is_ca":false},{"name":"Paul A. Bunn","is_ca":false},{"name":"Matthew Smeltzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2457151774760374,"gpt":0.6083806683625385,"spread":0.3626654908865011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3146085,0.001218792,0.006291664,0.004423518,0.001828717,0.01177263,0.003512443,0.01015326,0.01356288],"category_scores_gemma":[0.6474525,0.002079781,0.008350548,0.008746885,0.005346655,0.01602082,0.004418953,0.009058268,0.002013164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01151073,"about_ca_system_score_gemma":0.03316027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01128837,"about_ca_topic_score_gemma":0.02277695,"domain_scores_codex":[0.5561699,0.3540484,0.05308107,0.007339857,0.02659844,0.002762392],"domain_scores_gemma":[0.224891,0.6606819,0.04757576,0.01406413,0.04864511,0.004142093],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004066978,0.0001474068,0.004970016,0.3875201,0.01356715,0.0001620725,0.002867953,0.0005750811,0.0002620819,0.01390161,0.1314083,0.4405514],"study_design_scores_gemma":[0.00329308,0.0008810684,0.005244466,0.7343824,0.01367249,0.000209765,0.001392025,0.0004961457,0.0002344308,0.01616288,0.2238654,0.0001659258],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.001197985,0.8662244,0.0009926627,0.1202869,0.006279137,0.001164487,0.0009211074,0.00006917453,0.002864108],"genre_scores_gemma":[0.07237463,0.6325811,0.01204334,0.2542978,0.01440524,0.01113134,0.00139904,0.0003387533,0.001428759],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6853915,"threshold_uncertainty_score":0.8452098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399705963","doi":"10.1016/j.jtocrr.2024.100697","title":"Brief Report: Real-World Treatment Patterns and Clinical Outcomes for Patients With Advanced ALK-Rearranged NSCLC in British Columbia","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Cancer Research Society; Cancer Research Foundation","keywords":"Medicine; Oncology; Lung cancer; Internal medicine","authors":[{"name":"Peiyao Wang","is_ca":false},{"name":"Curtis Hughesman","is_ca":false},{"name":"Stephen Yip","is_ca":true},{"name":"William W. Lockwood","is_ca":true},{"name":"Sophie Sun","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0655007970993161,"gpt":0.487848837616346,"spread":0.4223480405170299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002987595,0.0001531337,0.000222751,0.001362534,0.0008652457,0.001030241,0.000503909,0.00040821,0.002160099],"category_scores_gemma":[0.001517902,0.0001619774,0.0001655544,0.002995595,0.0003024072,0.0002963284,0.0004734051,0.0003197592,0.0004717766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005090176,"about_ca_system_score_gemma":0.004375996,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7482633,"about_ca_topic_score_gemma":0.8352535,"domain_scores_codex":[0.9994903,0.00004986451,0.00006813857,0.00009124742,0.0001720704,0.0001284535],"domain_scores_gemma":[0.9977022,0.0001594331,0.0006142629,0.00007672368,0.000972882,0.0004744927],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002837939,0.00001225242,0.994716,0.00002646073,0.00001440849,0.0001773202,0.0001176189,0.00003301301,0.0001087654,0.000008510174,0.001935826,0.002821461],"study_design_scores_gemma":[0.000003775848,0.00001487346,0.9972473,0.00002465527,0.000009608654,0.0004242957,0.0004468126,0.000102984,0.00004657495,0.000009482871,0.001663514,0.000006173024],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793594,0.001292943,0.00009282277,0.0006444677,0.00004008847,0.00004885319,0.01517734,0.00002542168,0.00331874],"genre_scores_gemma":[0.9900556,0.0008637678,0.0001849949,0.0002040473,0.00003160176,0.00002559923,0.007610902,0.00001037224,0.001013144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2517367,"threshold_uncertainty_score":0.5064384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399705795","doi":"10.1016/j.jtocrr.2024.100696","title":"Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Center (category theory); Tertiary care; Stage (stratigraphy); Medicine; Lung cancer; Cancer; Clinical trial; Oncology; Internal medicine; Family medicine","authors":[{"name":"Navdeep Dehar","is_ca":true},{"name":"Mahbuba Meem","is_ca":true},{"name":"Ishita Aggarwal","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true},{"name":"A. Robinson","is_ca":true},{"name":"Andrea S. Fung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2734519420320826,"gpt":0.6070180270986795,"spread":0.3335660850665969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01656518,0.0001966831,0.0005796512,0.0005953741,0.0008226293,0.002089607,0.0004472736,0.00119933,0.007304185],"category_scores_gemma":[0.06056952,0.0001821878,0.0004387855,0.001150919,0.0005273495,0.0008516731,0.0008573838,0.000972134,0.0008609565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001355264,"about_ca_system_score_gemma":0.003240998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008010269,"about_ca_topic_score_gemma":0.001661254,"domain_scores_codex":[0.9864668,0.007972154,0.002833038,0.0006017511,0.001576262,0.0005499839],"domain_scores_gemma":[0.882611,0.059377,0.03884557,0.003851233,0.007999564,0.007315625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01402534,0.001030555,0.6179408,0.004651741,0.0005264371,0.002204367,0.001185888,0.0009053101,0.001893713,0.001150742,0.1627201,0.191765],"study_design_scores_gemma":[0.007528563,0.009826351,0.7399188,0.002411758,0.0007294689,0.006632715,0.00137171,0.002739768,0.003174739,0.002115298,0.2233625,0.000188349],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.865025,0.01647322,0.003152733,0.05710381,0.001752772,0.008026174,0.01709394,0.0002860315,0.0310863],"genre_scores_gemma":[0.9642015,0.003795974,0.003932028,0.01094173,0.003801903,0.003392673,0.006135509,0.00006199094,0.003736699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01656518,"threshold_uncertainty_score":0.08760613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7114800430","doi":"10.1016/j.jtocrr.2025.100944","title":"Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies","year":2025,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"International Association for the Study of Lung Cancer","keywords":"Targeted therapy; Lung; Cell; Cell therapy; Acquired resistance; Immunotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07505819556033028,"gpt":0.5350332632889704,"spread":0.4599750677286401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002567526,0.0004936958,0.001282651,0.001034994,0.0003133839,0.002331026,0.0009526091,0.001424579,0.001082074],"category_scores_gemma":[0.001074773,0.0002113434,0.0004550343,0.0005555935,0.002022148,0.003539842,0.001099546,0.00348233,0.0003178307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009510629,"about_ca_system_score_gemma":0.001016479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003423359,"about_ca_topic_score_gemma":0.0007912393,"domain_scores_codex":[0.9995085,0.0001467632,0.00006277639,0.00007110221,0.0001403416,0.0000705289],"domain_scores_gemma":[0.9991054,0.0004835582,0.0001436707,0.00004540467,0.0001214297,0.0001004911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004012948,0.0004455384,0.002598729,0.004529251,0.0001349481,0.0009624033,0.0004900793,0.000848019,0.01904741,0.0524284,0.01662353,0.9014904],"study_design_scores_gemma":[0.0002551412,0.003216562,0.008216752,0.004572352,0.0005090126,0.01007072,0.001781867,0.005428055,0.01562546,0.1090952,0.8410642,0.0001647169],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004145064,0.9780995,0.0031185,0.01223781,0.0004731131,0.00001857529,0.00001936061,0.00004455471,0.001843528],"genre_scores_gemma":[0.04176838,0.9441527,0.003890225,0.005349833,0.003264605,0.00006923964,0.00005428222,0.00001698046,0.001433734],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002567526,"threshold_uncertainty_score":0.01357853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391065397","doi":"10.1016/j.jtocrr.2024.100633","title":"A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Royal Melbourne Hospital; University of Melbourne; Institut National de la Santé et de la Recherche Médicale; AstraZeneca; Bristol-Myers Squibb","keywords":"Observational study; Lung cancer; Physical activity; Medicine; Physical fitness; Cancer; Prospective cohort study; Physical therapy; Oncology; Gerontology; Environmental health; Internal medicine","authors":[{"name":"Asha Bonney","is_ca":false},{"name":"Catherine L. Granger","is_ca":false},{"name":"Daniel Steinfort","is_ca":false},{"name":"Henry Marshall","is_ca":false},{"name":"Emily Stone","is_ca":false},{"name":"Annette McWilliams","is_ca":false},{"name":"Fraser Brims","is_ca":false},{"name":"Paul Fogarty","is_ca":false},{"name":"Linda Lin","is_ca":false},{"name":"Jiashi Li","is_ca":false},{"name":"Siyuan Pang","is_ca":false},{"name":"Stephen Lam","is_ca":true},{"name":"Kwun M. Fong","is_ca":false},{"name":"Renée Manser","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2351276828401595,"gpt":0.5323852277702925,"spread":0.297257544930133,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001215831,0.0003074023,0.00066504,0.0005543066,0.0006967906,0.0007146175,0.0005193172,0.0007611151,0.001499834],"category_scores_gemma":[0.002327521,0.0005432159,0.0005678464,0.00119264,0.00027335,0.0006898048,0.0006230414,0.001141896,0.0005637908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002594282,"about_ca_system_score_gemma":0.0006011285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006672261,"about_ca_topic_score_gemma":0.008473749,"domain_scores_codex":[0.9991212,0.0002718541,0.0000957986,0.0001983165,0.0001894152,0.000123455],"domain_scores_gemma":[0.9985572,0.0001736319,0.0004718525,0.0001562586,0.0002125212,0.0004285586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002169142,0.000169029,0.9986798,0.00002279999,0.00008827928,0.00004652169,0.00009191217,0.000008915024,0.0001328134,0.000006564893,0.000118015,0.0004184056],"study_design_scores_gemma":[0.00004654804,0.0003464013,0.9990883,0.000009494111,0.00003990318,0.0001023397,0.0001471497,0.00004689438,0.00001065808,0.00001042416,0.0001489568,0.000002856679],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975363,0.0002196842,0.0001289272,0.00004452115,0.0000123105,0.00009358196,0.001431748,0.000004196024,0.0005287393],"genre_scores_gemma":[0.9977375,0.0001251858,0.0002148599,0.0001128454,0.00001965203,0.0001622219,0.001343109,0.000002306931,0.0002821973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006672261,"threshold_uncertainty_score":0.01326686,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214510639","doi":"10.1016/j.jtocrr.2022.100304","title":"Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Cancer; Carboplatin; Internal medicine; Oncology; Stage (stratigraphy); Biomarker; Targeted therapy; Disease; Chemotherapy; Biology","authors":[{"name":"Achille Manirakiza","is_ca":false},{"name":"Fidel Rubagumya","is_ca":true},{"name":"Eulade Rugengamanzi","is_ca":false},{"name":"Alphonsine Mukandekezi","is_ca":false},{"name":"Jessica Beneyo","is_ca":false},{"name":"Maurice Musoni","is_ca":false},{"name":"Thierry Zawadi Muvunyi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.155052970415355,"gpt":0.5397272122547654,"spread":0.3846742418394103,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006637799,0.0001735159,0.0001626027,0.001278478,0.0004950041,0.0009814304,0.000515674,0.0005587874,0.002617656],"category_scores_gemma":[0.004339814,0.0001933919,0.000231724,0.002634546,0.0004766038,0.0008197746,0.0006127546,0.0008619432,0.0005322361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002639964,"about_ca_system_score_gemma":0.002531589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02051978,"about_ca_topic_score_gemma":0.02174817,"domain_scores_codex":[0.9991509,0.0001167845,0.00007207107,0.0001425222,0.0001950728,0.0003226116],"domain_scores_gemma":[0.9947526,0.0007776015,0.002776047,0.00009884053,0.000894957,0.0006998561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005800001,0.00002597362,0.9845327,0.00006684252,0.0000167099,0.0003650802,0.0004495431,0.0001782251,0.0006944652,0.0001644824,0.00138757,0.01206041],"study_design_scores_gemma":[0.000004059217,0.00006507146,0.9940201,0.00005282332,0.00001303137,0.0009961047,0.001656108,0.0001742313,0.0003297433,0.00005202511,0.002627576,0.000009219419],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876253,0.003089712,0.0002166335,0.004681482,0.00003267095,0.00001817746,0.001264481,0.000027965,0.00304369],"genre_scores_gemma":[0.9960957,0.002223752,0.0002202965,0.0003829978,0.00005268181,0.00001281407,0.0005705426,0.000005401263,0.0004358086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02051978,"threshold_uncertainty_score":0.04080069,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4414439969","doi":"10.1016/j.jtocrr.2025.100910","title":"Risk Factors Associated With Incidence of Lung Cancer in Never-Smokers: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"JTO Clinical and Research Reports","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Cancer Research UK; National Institute for Health and Care Research; Entertainment Industry Foundation; American Lung Association; American Association for Cancer Research","keywords":"Lung cancer; Incidence (geometry); Risk factor; Epidemiology; Cancer; Population","authors":[{"name":"SB Naidu","is_ca":false},{"name":"Allegra Wisking","is_ca":false},{"name":"Akul Karoshi","is_ca":false},{"name":"Sarah Burdett","is_ca":false},{"name":"Peter J. Godolphin","is_ca":false},{"name":"Sanjay Popat","is_ca":false},{"name":"Sam M. Janes","is_ca":false},{"name":"Neal Navani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3500971598906501,"gpt":0.5673434307207585,"spread":0.2172462708301084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009102172,0.002344478,0.01638082,0.005952742,0.0007169098,0.003094085,0.001893457,0.002069182,0.003579421],"category_scores_gemma":[0.02557919,0.001463074,0.03357614,0.006785981,0.0006682497,0.001577729,0.001360204,0.001798718,0.0003098164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002161343,"about_ca_system_score_gemma":0.003580666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00744122,"about_ca_topic_score_gemma":0.01701348,"domain_scores_codex":[0.9932885,0.002754451,0.00203688,0.0007994745,0.0008603317,0.0002603687],"domain_scores_gemma":[0.9844395,0.01141496,0.002367201,0.0004271294,0.001145744,0.0002055089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001226325,0.00002537001,0.007618672,0.453202,0.5259507,0.0001684169,0.00009754225,0.0005320139,0.0001858456,0.0001192889,0.0008790997,0.009994791],"study_design_scores_gemma":[0.000306277,0.0001280195,0.00513243,0.03537815,0.9568291,0.0001340036,0.00004389397,0.0001996286,0.00008432012,0.0001517571,0.001588056,0.00002440846],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004395314,0.9939846,0.0003479572,0.0001753576,0.00008959867,0.0002061893,0.0005408737,0.00002221113,0.0002379098],"genre_scores_gemma":[0.1498494,0.8449727,0.001793255,0.0007952471,0.0002419748,0.0009264473,0.001039247,0.00002874455,0.0003530569],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01638082,"threshold_uncertainty_score":0.04813743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}